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Abstract
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels which 
exhibit considerable subunit diversity. They have been implicated in processes 
including synaptic transmission and modulation of neurotransmitter release. They 
also have a significant role in several pathological disorders as well as nicotine 
addiction, which makes nAChRs important targets for therapeutic drug discovery.
One of the aims of this study was to investigate the influence of the intracellular 
domain of nAChR subunits upon receptor assembly, targeting and functional 
properties. A series of subunit chimaeras was constructed, each containing the 
intracellular loop region, located between transmembrane (TM) domains M3 and 
M4, from nAChR subunits al-alO  or p i -04 and from the 5-hydroxytryptamine 
type 3 receptor (5 -HT3R) subunits 3 A and 3B. Evidence has been obtained which 
demonstrates that the large intracellular loop exerts a significant influence upon 
the levels o f both cell-surface and intracellular assembled receptors. Comparisons 
o f functional ion-channel properties revealed a significant influence upon both 
single-channel conductance and receptor desensitisation. Experiments conducted 
in polarised epithelial cells demonstrate that the nAChR loop can also influence 
receptor targeting.
In a further study, the influence of the recently identified nAChR molecular 
chaperone, RIC-3 (resistance to inhibitors of cholinesterase), on receptor 
maturation was investigated. The influence of subunit domains upon the RIC-3’s 
chaperone activity was investigated by co-expression with subunit chimaeras.
Finally, a9/5-HT3A and alO/5-HT3A subunit chimeras were used to investigate the 
pharmacological properties o f a9 a l0  nAChRs, a receptor subtype expressed in 
hair cells of the auditory system. Physiologically relevant concentrations of the 
anti-malarial compounds, quinine, quinidine and chloroquine were shown to act as 
competitive inhibitors, whereas the NMDA receptor antagonist, neramexane, 
blocked a9 a l0  nAChR mediated responses via a non-competitive mechanism.
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Chapter 1 
Introduction
1.1 Discovery of the nicotinic acetylcholine receptor -  a brief 
history
“7 shall never bend this bow again. ”
These were reported as the last words of a native South American Indian, looking 
at his bow, immediately after accidentally shooting himself with a poison-tipped 
arrow while hunting (Waterton, 1879). The poison in question was ‘curare’, 
which causes death through rapid muscle paralysis leading to asphyxiation. 
Various South American tribes have for centuries prepared curare-containing 
mixtures from the vine-like plants Strychnos toxifera, Chondrodendron 
tomentosum and related species. The preparation of curare was first described by 
the naturalist and explorer Alexander von Humboldt (von Humboldt and 
Bonpland, 1807), although explorers to the New World had reported the use and 
deadly effects of poisoned arrows as early as the 16th century (Raleigh, 1596).
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During the mid 19th century, Claude Bernard undertook a detailed scientific study 
of curare on samples returned to Europe and was able to determine that the poison 
interrupted signalling between a nerve and the striated muscle it innervated, while 
leaving smooth and cardiac muscle unaffected. He found that after curare- 
induced paralysis of a frog, the muscles could be induced to contract by direct 
electrical stimulation, but not through stimulation of the associated nerves 
(Bernard, 1850). While Bernard thought that the nerve terminal was ‘paralysed’ 
by curare, it was Arthur Vulpian who later determined that curare acted on, what 
he described as an ‘intermediate zone’ between the nerve terminal and the muscle 
(Vulpian, 1866), at the motor endplate region, whose morphology had by then 
recently been described (Kuhne, 1863). Later, John Langley demonstrated using 
denervated muscle that curare acted on what he coined a ‘receptive substance’ 
associated with the muscle, as opposed to the nerve or the ‘fundamental 
substance’ of the muscle itself. Langley also worked with the alkaloid nicotine 
(from the Solanaceae family of plants), and discovered that both curare and 
nicotine acted as mutual antagonists of each other’s effects on muscle contraction; 
nicotine stimulating (at low concentrations), and curare blocking (Langley, 1905). 
Around this time the immunologist Paul Erlich independently developed his ‘lock 
and key’ hypothesis to describe the action of toxins on the ‘receptive side chains’ 
of cells. Taken together with Langley’s studies, and the theory of chemical 
transmission first proposed by Du Bois-Reymond (du Bois-Reymond, 1877), the 
concept of ‘chemical transmitters’ and ‘receptors’ emerged (Langley, 1906). 
Henry Dale later identified acetylcholine as a possible candidate molecule for a
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chemical transmitter and described how the alkaloids muscarine and nicotine 
mimicked the effects of acetylcholine on smooth and striated muscle, respectively 
(Dale, 1914), which could be blocked by atropine and (+)-tubocurarine (the active 
component of curare), respectively. However, it was not until Otto Loewi’s 
famously simple and elegant experiment on the autonomic innervation of two 
isolated beating frog hearts, that the idea of chemical transmission was decisively 
demonstrated (Loewi, 1921). Loewi named the chemical transmitter released 
upon electrical stimulation of the vagus nerve ‘ Vagusstoff (vagus substance) and 
demonstrated that, when transferred to a second denervated and isolated heart, it 
elicited the same response as observed in the donor heart -  specifically, a 
reduction in contraction. Vagusstoff was later identified to be acetylcholine (Dale 
and Feldberg, 1934), and was also shown to be the endogenous chemical 
transmitter released by motor neurones innervating voluntary striated muscle, 
leading to muscle contraction (Dale et al., 1936).
Soon after acetylcholine had been identified as the transmitter at the 
neuromuscular junction, the cholinergic nature of transmission in the electric 
organ (electroplaque tissue) of the marine ray Torpedo marmorata was 
established (Feldberg et a l , 1939). This tissue, embryonically derived from 
myoblasts, is common to all electric fish (including the electric eel, Electrophorus 
electricus). It produces an electrical discharge, in order to stun prey and deter 
predators, which can be blocked by the action of curare. The rich cholinergic 
innervation of post-synaptic membranes found in these electric organs made them
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an ideal source from which to isolate and purify the acetylcholine receptor in 
sufficient quantities to enable further biochemical, pharmacological and structural 
studies. This was greatly facilitated by the discovery of the acetylcholine receptor 
ligand, a-bungarotoxin, which binds to the receptor practically irreversibly and 
with high affinity. This toxin was first isolated from the snake venom of the 
Formosan banded krait, Bungarus multicinctus, based on its ability to cause a 
block of neurotransmission in a manner qualitatively similar to curare poisoning 
(Chang and Lee, 1963). Indeed, (+)-tubocurarine protects against the blocking 
action of a-bungarotoxin, indicating that both compounds bind to the same site of 
the acetylcholine receptor found at the motor endplate (Lee and Chang, 1966).
The potent and highly selective a-bungarotoxin was used to isolate large 
quantities of the nicotinic acetylcholine receptor protein (Langley’s “receptive 
substance”), from the electric organs of the electric eel, Electrophorus electricus 
(Changeux et al., 1970), and the electric ray, Torpedo marmorata (Miledi et a l,  
1971). The abundant source of pure receptor protein, which could now readily be 
studied, soon established the nicotinic acetylcholine receptor, as the prototypic 
ligand-gated ion channel.
It is interesting to note, as a brief aside, that during his 1799-1804 exploration of 
the Americas, Alexander von Humboldt encountered, and for the first time studied 
in detail, the anatomy and behaviour of the electric eel, Electrophorous electricus 
(von Humboldt, 1808). As discussed above, it was on the very same trip that he
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also described the preparation and effects of the poison curare (von Humboldt and 
Bonpland, 1807). It is unlikely that he could ever have imagined that both would 
come together again in the future, so crucially, in isolating the nicotinic 
acetylcholine receptor and, as a result, encourage the many related advances in 
physiology and medicine that have occurred since.
1.2 The neurotransmitter acetylcholine (ACh) and its receptors
1.2.1 Acetylcholine and cholinergic transmission
Acetylcholine was the first neurotransmitter to be described (Dale, 1914), and is 
perhaps the best characterised neurotransmitter to date. Acetylcholine is a low- 
molecular weight (146.2 g/mol) chemical transmitter synthesised in neurones by 
the enzyme choline acetyltransferase from the compounds choline and acetyl 
coenzyme A. Neurones containing the enzyme choline acetyltransferase are 
typically termed cholinergic neurones and regulate neural transmission, through 
the release o f ACh, in the central and peripheral nervous systems (CNS and PNS, 
respectively). ACh is rapidly broken down by the enzyme acetylcholine esterase, 
which is found in the synaptic clefts of cholinergic synapses and limits the size 
and duration of the postsynaptic potential.
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1.2.2 Nicotinic and muscarinic acetylcholine receptors
As described above (Section 1.1), the neurotransmitter ACh acts on two main 
receptor subtypes which have been pharmacologically subdivided into ‘nicotinic’ 
AChRs (nAChRs) and ‘muscarinic’ AChRs (mAChRs); so classified due to the 
acetylcholine-mimicking effects of the alkaloids nicotine (from the Solanaceae 
plant family), and muscarine (first isolated from the mushroom Amanita 
muscaria), respectively. Despite a common activation by acetylcholine, both 
types of receptor are structurally distinct and are not closely related. The nAChRs 
are referred to as ‘ionotropic’ receptors which form an ion channel in the cell 
membrane and belong to the superfamily of ligand-gated ion channels (LGICs) 
known as Cys-loop receptors (Ortells and Lunt, 1995; Sine and Engel, 2006). The 
mAChRs are referred to as ‘metabotropic’ receptors and belong to the family of 
seven-transmembrane G-protein coupled receptors (GPCRs), which mediate their 
effects via heterotrimeric GTP-binding proteins (G-proteins; Ishii and Kurachi, 
2006).
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1.3 The nicotinic acetylcholine receptor (nAChR)
1.3.1 The Cys-loop superfamily of ligand gated ion channels
The nAChRs belong to a sub-family of LGICs known as Cys-loop receptors, 
which are characterised by a conserved Cys-loop signature motif, consisting of 
two disulphide-bonded cysteines separated by 13 residues within the amino (ISO- 
terminal domain o f all members of this family. The Cys-loop family of receptors 
includes 5-hydroxytryptamine (or serotonin) type 3 (5 -HT3) receptors, y- 
aminobutyric acid type A (GABAa) and type C (GABAc) receptors, glycine 
receptors, and some invertebrate glutamate and histidine receptors (Karlin, 2002; 
Connolly and Wafford, 2004; Millar, 2006). All members of the Cys-loop family 
are thought to possess a similar structural architecture consisting of five 
homologous subunits arranged in a ring to form a central ion-permeable pore 
(Figure 1.1). Individual subunits are composed of three structurally distinct 
domains: a large extracellular N-terminal domain, primarily made up of P-pleated 
sheets, four a-helical transmembrane spanning domains (M l, M2, M3 and M4), 
and a large, structurally ill-defined, intracellular loop of variable length between 
M3 and M4 (Figure 1.1). While nAChRs and 5 -HT3RS are cation permeable, 
mediating excitatory transmission, the other members of this group are anion 
permeable and mediate inhibitory transmission. Comparison of the nucleotide 
sequence of genes within the Cys-loop family of ligand-gated ion channel
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Figure 1.1 The predicted membrane topology o f a Cys-loop receptor subunit and the 
pentam eric structure o f an assembled receptor. Schematic representation o f  the membrane 
topology o f  a subunit from the Cys-loop family o f  receptors (left panel), showing three distinct 
subunit domains: The large extracellular N-terminal domain, the four transmembrane domains 
(M1-M 4, represented by black cylinders) and the variable length M3-M4 intracellular loop 
domain. The subunits are arranged in a pentamer (right panel), forming a central ion- 
permeable channel through the plasma membrane, allowing ions to pass from the extracellular 
side o f  the membrane to the intracellular side. The channel can conduct both cations and 
anions depending on the particular Cys-loop family receptor subtype in question (e.g. nAChRs 
and GABA aRs, respectively). Diagram reproduced with permission (Millar, 2003).
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suggests that all the members originate from a common ancestral gene (Ortells 
and Lunt, 1995).
1.3.2 The nAChR of the fish electric organ
The electric organs of the freshwater electric eel, Electrophorus electricus, and 
marine electric rays like Torpedo californica and T. marmorata, are composed of 
rows or columns of cells termed electroplaques or electrocytes, which are derived 
from muscle cells and are capable of producing an electrical discharge via ACh 
mediated depolarisation. The electroplaques are arranged in such a way that upon 
nAChR activation a voltage difference accumulates across many cells enabling 
the fish to discharge enough current to stun prey. In order to fulfil their 
specialised role, electroplaques are highly innervated with cholinergic projections 
and densely packed with nAChRs, thereby providing an abundant source of 
receptors for isolation.
The elapid snake toxin a-bungarotoxin (aBTX), isolated from the venom of the 
Formosan banded krait Bungarus multicinctus (Chang and Lee, 1963), is a potent 
nicotinic receptor antagonist and was used to isolate and purify nAChRs from 
Electrophorus electricus (Changeux et al., 1970). The aBTX protein is a 
polypeptide of 74 amino acids with a molecular weight of around 8000 Da. It 
consists primarily of p-sheet secondary structure and contains five disulphide 
bonds (Love and Stroud, 1986). The specific high affinity binding of aBTX to the
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nAChR has been exploited extensively in the characterisation of the receptor and 
has helped to reveal many of its biochemical and pharmacological properties.
The nAChR of the fish electric organ is an integral membrane-spanning 
glycoprotein composed of five homologous subunits (Brisson and Unwin, 1985). 
The receptor can exist as a pentameric monomer of -250 kDa and a disulphide- 
linked dimer of -500 kDa, which migrate on a sucrose gradient with 
sedimentation coefficients of 9 S and 13 S, respectively (Gibson et al., 1976; 
Reynolds and Karlin, 1978). The pentameric nAChR is composed of four types 
of subunits termed a, p, y and 5, which were named according to their increasing 
apparent molecular weight of approximately 40 kDa, 48 kDa, 62 kDa and 66 kDa, 
respectively, as determined by SDS-PAGE of purified nAChR preparations from 
Torpedo (Hucho et a l , 1976). The four subunits are arranged with a 
stoichiometry of (X2Py5, and combine to form a ring-like structure around an axis 
perpendicular to the plane of the membrane, creating a central ion-conducting 
channel pore (Unwin, 1993).
1.3.3 The nAChR of the vertebrate neuromuscular junction
The nAChR of the vertebrate neuromuscular junction (NMJ) is, to date, one of the 
best characterised LGICs as regards structure and function. Electrophysiological 
properties such as channel gating, conductance and desensitisation have been well 
defined (Peper et al., 1982; Sakmann and Neher, 1984; Colquhoun and Ogden,
1988). Action potentials reaching the motor nerve endings stimulate the release
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of acetylcholine from the pre-synaptic membrane; these then diffuse about 50 nm 
across the synaptic cleft to the post-synaptic membrane. Acetylcholine in the 
synaptic cleft rapidly reaches concentrations in the range of 0.1-1.0 mM (Katz and 
Miledi, 1977). At the post-synaptic membrane two molecules of acetylcholine 
bind per nAChR (Adams, 1981), causing a conformational change within the 
receptor, allowing cations (principally sodium, but also potassium and calcium) to 
flow through the ion-channel pore and across the plasma membrane. The 
resulting depolarisation of the muscle cell results in the eventual contraction of the 
muscle fibre. The entire process, from activation of the motor neuron to muscle 
fibre contraction, occurs in less than 100 ps (Adams, 1981; Peper et a l,  1982). 
Activation of nAChRs is terminated within a few milliseconds through the natural 
diffusion of ACh which is then rapidly hydrolysed by acetylcholine esterase 
(Katz and Miledi, 1977).
It became clear that the nAChR located at the cholinergic synapse of the 
vertebrate neuromuscular junction was structurally related to the nAChR of the 
fish electric organ. In both systems, nerve transmission is blocked by the action 
of antagonists such as (+)-tubocurarine and aBTX. The purified mammalian 
muscle nAChR was found to sediment with a similar buoyant density to the 
nAChR from the electric organ and consist of four subunit components (Froehner 
et a l,  1977). Monoclonal antibodies raised against individual Torpedo nAChR 
subunits crossreact with mammalian muscle nAChR subunits and injection of any 
one of the four Torpedo nAChR subunits can elicit an auto-immune response in
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rats against their own nAChRs (Lindstrom et a l , 1978; Lindstrom et a l,  1979). 
From sequence similarity, it is clear that the nAChR of the vertebrate NMJ and 
that of the electric fish have high structural similarity (Section 1.4). Through 
molecular cloning techniques (Section 1.3.7), an additional y-like subunit (termed 
e) has been identified in vertebrate muscle (Takai et a l,  1985) which is not 
present in the fish electric organ nAChR.
The nAChR in mammalian muscle exists as one of two homogeneous receptor 
populations, each type expressed according to the developmental stage of the 
animal. Both species of receptor share common a  p and 5 subunits, but the y 
subunit is only expressed in embryonic (and denervated) muscle and is later 
replaced, in a developmental switch, for the e subunit found in adult muscle. 
Electrophysiological analysis of recombinant nAChRs containing a  p, y and 5 
subunits expressed in Xenopus laevis oocytes, revealed conductance estimates 
(-39 pS) resembling those typical of foetal muscle; while Xenopus oocytes 
expressing a p, 5 and 8 subunits formed nAChR channels with conductance 
estimates (-59 pS) more closely resembling the channels found at the adult NMJ 
(Mishina et a l , 1986).
1.3.4 Neuronal nAChRs
The neurotoxin aBTX, in addition to binding to the muscle nAChR, also exhibits 
high-affinity binding in the CNS and PNS (Greene et a l,  1973; Hunt and 
Schmidt, 1978). However, unlike the situation at the neuromuscular junction,
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aBTX binding and blockade of nicotine-mediated synaptic transmission in 
nervous tissue are not strongly coupled events (Quik and Geertsen, 1988). It was 
found that in a number of cases, aBTX was unable to block nicotine-mediated 
transmission in vertebrate neurones and radiolabeled aBTX only partially co­
localised with nicotine binding sites (Clarke et al., 1985; Schuetze and Role,
1987). Antiserum raised against the nAChR of Electrophorus electricus was 
shown to block responses elicited by nicotine from the rat phaeochromocytoma 
(PC-12) cell line, but failed to precipitate the aBTX-binding component (Patrick 
and Stallcup, 1977a; Patrick and Stallcup, 1977b). In contrast aBTX does 
effectively block nicotine-evoked responses in vertebrate neurones (Marshall, 
1981). It was thus suggested that two classes of receptors structurally 
homologous to the nAChR in muscle and electric fish exist in the nervous system; 
those that are aBTX sensitive and those that are aBTX insensitive (McGehee and 
Role, 1995).
Molecular cloning techniques have identified twelve vertebrate neuronal nAChRs. 
These have been grouped into the ‘a-type’ neuronal nAChR subunits (a2-al0), 
and the ‘non a-type’ neuronal nAChR subunits (pl-p4). The a  subunits are so 
defined because they share a pair of conserved adjacent cysteine residues 
(equivalent to positions 192 and 193 of the Torpedo a subunit), which make up 
part of the agonist-binding site. The p subunits lack these conserved residues. 
Interestingly, the a8 subunit has been discovered only in chick (Schoepfer et al., 
1990), and appears to have no mammalian homologue. Unlike the homogeneous
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receptor population of their muscle-type counterparts, neuronal nAChRs exist as a 
diverse group of receptors, drawing on a much larger repertoire of subunits with 
which to make up the receptor complex (Le Novere et a l , 2002; Millar, 2003).
Neuronal nAChRs exist as homomeric complexes made up of five identical 
subunits (e.g. a7), or as heteromeric complexes containing two or more types of 
subunit (e.g. a4p2 and a4a5p2). Not all subunits can co-assemble with each 
other to generate functional receptors, but there appears to be extensive diversity 
in subunit composition of neuronal nAChRs (Le Novere et al., 2002; Millar, 
2003).
1.3.5 Cloning of nAChRs
Soon after the first isolation and purification of nAChRs from the electric organs 
of the fish, Electrophorus electricus and Torpedo marmorata (Changeux et al., 
1970 and Miledi et a l , 1971, respectively), the first 54-56 amino acids from each 
of the purified polypeptides comprising the isolated protein complex were 
determined by protein sequencing (Raftery et a l, 1980). Using this amino acid 
sequence information, the first nAChR genes (encoding the subunits a, p, y and 8) 
were identified and cloned from the electric organ of Torpedo californica and 
their primary structure deduced (Noda et a l,  1982; Noda et a l,  1983a; Noda et 
a l,  1983b). The cloning of the Torpedo nAChR subunits rapidly led to the 
identification of other nAChR subunits. Seventeen vertebrate nAChR subunits
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have been cloned and characterised (al-alO , pl-p4, y, 8 and e). As described 
above, the a l ,  p i, y and 8 subunits comprise the nAChR which is found in 
denervated or embryonic muscle and the electric organs of fish. In the adult 
neuromuscular junction, the y subunit is replaced by the e subunit. These subunits 
are referred to as ‘muscle-type’ nAChRs (Section 1.3.3). The remaining subunits 
make up the ‘neuronal-type’ nAChRs, based on their expression profiles within 
the CNS and PNS. With the advent of whole genome sequencing, a large number 
of nAChRs have also been identified from non-vertebrate species. Ten nAChR 
subunits in insects, such as the fruit fly Drosophila melanogaster (Millar and 
Denholm, 2007), and 29 nAChR subunits in the nematode Caenorhabditis 
elegans (Jones et a l , 2007), have to date been identified.
1.4 The structure of nAChRs
1.4.1 Primary protein structure of nAChR subunits
The primary amino-acid sequences of all the nAChR subunits have approximately 
40-50% amino-acid sequence similarity and all are believed to share a similar 
membrane topology with the other members of the Cys-loop receptor family 
(Lester et al., 2004). Each nAChR subunit contains an N-terminal signal 
sequence of around 20 amino acids which is cleaved from the mature protein 
polypeptide. The N-terminal portion of the protein constitutes a large hydrophilic
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extracellular domain containing asparagine (N)-linked glycosylation sites (See 
Section 1.5.2). The N-terminal domain consists largely of a p-sheet structure with 
interconnecting hairpin-loop turns (Unwin, 2005). It contains a conserved 15 
amino-acid Cys-loop, formed by the disulphide linkage of residues which align to 
C128 and C142 of the Torpedo a l subunit and is characteristic of all members of the 
receptor family (See Section 1.3.1). The N-terminal domain includes sequences 
which make up the ligand binding site (Sine, 2002). Sequence analysis and 
hydrophobicity plots indicate that there are four hydrophobic, putative 
transmembrane spanning domains termed M l, M2, M3 and M4, which are highly 
conserved throughout the subunit family and are generally accepted to adopt an a- 
helical structure (Unwin, 2005). The M2 a-helices of each of the five subunits 
which comprise the assembled nAChR line the channel pore and act as a 
selectivity filter and gate for ion flow through the channel (Imoto et a l, 1988). 
There is a large cytoplasmic loop between the transmembrane domains M3 and 
M4, which displays the greatest sequence variability between subunits and 
contains several potential sites of phosphorylation (Huganir and Greengard, 1990; 
Moss and Henley, 2002). A possible consequence of the variability of the large 
M3-M4 cytoplasmic loop is that intracellular molecular interactions could be 
specific to certain subunits and receptors. This may provide a mechanism by 
which receptors can be selectively modulated and targeted. Subunit protein 
sequences terminate with a short C-terminal domain located on the extracellular 
face of the membrane.
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1.4.2 Stoichiometry and arrangement of subunits
The nAChR of the Torpedo electric organ is arranged as a pentamer with the 
stoichiometry o^pyS (Unwin, 1993). It can exist as a monomer or as a dimer in 
which two receptor monomers are linked via a disulphide bridge between the 
penultimate cysteine residues of the 8 subunits (DiPaola et a l, 1989). Data 
obtained from electron diffraction studies of Torpedo nAChR have revealed that 
the subunits are arranged around the central ion-pore in the clockwise order, a-y- 
a-p-8, as viewed from above the plane of the membrane (Figure 1.2; Unwin,
2005).
The nAChR in murine skeletal muscle has a predicted topology similar to that of 
the Torpedo receptor (Sealock, 1982). It is highly likely that the arrangement 
around the ion-channel pore for the muscle nAChRs is the same as the Torpedo 
receptor (based on sequence similarity), except that in adult muscle the position of 
the 8 subunit is replaced by the e subunit.
In both fish electric organ and vertebrate muscle nAChRs, the agonist-binding site 
has been mapped to the a-y and a-8 subunit interfaces. Affinity labelling 
experiments using competitive antagonists were found to label primarily the a 
subunits and, to a lesser extent, the y and 8 subunits (Pedersen and Cohen, 1990; 
Corringer et a l,  2000). The unequal levels of binding observed between the 
subunits (a l binding > y and 8 binding) suggested an asymmetric location of the
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binding site, with the a l subunit contributing a greater effect towards binding. 
Thus, the a l subunit has been termed the ‘principal component’ subunit, while the 
y and 8 were termed the ‘complementary component’ subunits of the ACh binding 
site (Corringer et a l,  1995; Corringer et a l, 2000).
Subunit stoichiometry is more complex in the heteromeric neuronal nAChRs, 
owing to the larger diversity of subunits available to form receptors. Two well- 
studied heteromeric receptors contain a4 and p2 subunits, and a3 and P4 subunits. 
These combinations are thought to have two a subunits and three P subunits but 
there is also evidence for alternative subunit stoichiometries (Zwart and 
Vijverberg, 1998; Nelson et a l, 2003). Heterologous expression studies in 
Xenopus oocytes have provided evidence for an a3p4 nAChR stoichiometry of 
(a3)2(P4)3, with the arrangement apapp (Boorman et a l,  2000). However, a4p2 
nAChRs can exist in two different stoichiometries in both oocytes and 
mammalian cells: (a4)2(p2)3 and (a4)3(P2)2, which exhibit differing functional 
properties (Zwart and Vijverberg, 1998; Nelson et a l,  2003). The lower-affmity 
(ACh EC50 = -100 pM) (a4)3(P2)2 stoichiometry predominates in mammalian 
cells and exposure to nicotine can up-regulate the levels of the p2 subunit and 
promote the expression of the higher-affmity (ACh EC50 = -1  pM) (a4)2(P2)3 
stoichiomtery (Moroni et a l,  2006). The stoichiometry of recombinant a9al0  
nAChRs has been shown in oocytes to be (a9)2(al0)3 (Plazas et a l,  2005). It has 
yet to be conclusively determined if the stoichiometries of recombinant receptors 
elucidated in heterologous expression systems truly represent those of native
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receptors, a matter which is further complicated by nAChR subtypes containing 
more than one type of a or p subunit (Lewis et a l,  1997; Millar, 2003). Some 
nAChR subunits are capable of forming homopentameric receptors (e.g. a7 and 
a9; (Couturier et al., 1990 and Elgoyhen et a l, 1994, respectively). It has been 
reported that homomeric a l  receptors have five binding sites for the ligand 
methyllycaconitine (MLA; Palma et a l, 1996), implying a pentameric structure. 
A summary of the diverse family of vertebrate nAChR subunits and the rules 
governing their assembly are briefly described in Table 1.1.
1.4.3 The three-dimensional structure of the nAChR
Electron microscopy studies of the Torpedo nAChR have yielded insights into the 
molecular and structural elements of the nAChR that underlie aspects of its 
function, such as agonist binding and gating. Tubular crystals of the postsynaptic 
membrane of electroplaque tissue analysed by cryo-electron microscopy have 
provided three-dimensional structural details of the nAChR (Figure 1.2) at a 
resolution of 17 A (Toyoshima and Unwin, 1988), 9 A (Unwin, 1993), and more 
recently, 4 A (Unwin, 2005).
The receptor has a length of about 160 A (or 16 nm), with the N-terminal domain 
protruding outwards from the membrane by about 80 A. The pentameric receptor 
is composed of subunits which all have dimensions approximately 30 A x 40 A x 
160 A (Unwin, 2005). The intracellular domain is the only part of the protein 
which remains unresolved in the three-dimensional structure, perhaps due to this
Subtype Family Tribe Subunits Combinations
Neuronal-type 
(non muscle-type)
1* a9, a10 a9a10fabl
II* a7, a8 a7[c) a8*[d]
Ilf
111.1
111.2
111.3
a2, a3, a4, a6 
p2, p4 
a5, p3
a2p4l®l a3a5p4[9hl 
a3p4fel a6p2p3[iJ1 
04P2CT a4a6p2p3M
Muscle-type IV*
IV. 1 
IV.2 
IV.3
a1
y, 5, e
P1
a1plY5w
a ip ie6 w
Table 1.1 Schematic summary of vertebrate nAChR subunit diversity and assembly.
Vertebrate nAChRs can be broadly classified as either ‘m uscle-type’ or ‘neuronal-type’/ ‘non 
m uscle-type’, depending on their expression profile (see main text). The nAChRs are further 
divided into four ‘fam ilies’ (I-IV) based on their sequence similarities and gene structure. The 
nAChR combinations in families I, II and IV are sensitive to the snake neurotoxin aBTX (*); while 
those in family III are aBTX-insensitive ( t ) .  Current evidence suggests that natively, the subunits 
a7 and a8 appear primarily to form homopentameric receptors, although there is also evidence 
from chick that they can co-assem ble with each other (for review see Millar, 2003). The two 
largest nAChR subunit families can be further subdivided into three ‘tribes’ (1-3; Le N overe et a l ,  
2002), depending on the role each subunit plays within the receptor com plex. Subunits forming 
the principal and complementary components o f  the ligand binding site belong to the 1st and 2nd 
tribe, respectively. The subunits which do not participate directly in the formation o f  the ligand 
binding site belong to the 3rd tribe. The rules o f  nAChR assembly require that heteromeric 
receptors are com posed o f  at least two subunits from each o f  the 1st and 2nd tribes e.g. (a4)2(P2)3, 
as found throughout the CNS; and may contain one subunit from the 3rd tribe e.g. ( a l ) 2pie5, as 
found at the adult NM J or a4a6(p2)2p3, as found in the retina and its projections. Members o f  the 
3rd tribe {e.g. a5 and P3) are often referred to as ‘orphan subunits’, since they cannot form a 
functional receptor without subunits from the 1st and 2nd tribes. N ote that not all o f  the receptor 
subunit combinations characterised to date are included in this table, which is intended as a 
simplified guide (for recent reviews see Millar, 2003; Gaimarri et al., 2007; and Gotti et a l ,  2007). 
t  The a8 subunit has been identified in avian species with no evidence for a mammalian 
homologue. [a, Elgoyhen etal.,  2001; b, Plazas, 2005; c, Couturier et al., 1990; d, Gerzanich etal., 
1994; e, Duvoisin et al., 1989; f, Papke et al., 1989; g, Fucile et al., 1997; h, Conroy and Berg, 
1995; i, Champtiaux etal.,  2003; i, Zoli etal., 2002; and k, Mishina et al., 19861
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being a less rigid part of the receptor, resulting in a more disordered region within 
the crystal. The only part of the intracellular loop to be resolved is the membrane 
associated (MA)-helix, which adopts a rigid structure in relation to the rest of the 
loop and constitutes the cytoplasmic vestibules of the nAChR, protruding 
approximately 50 A below the membrane (Peters et al., 2005; Unwin, 2005).
Recently, a molluscan acetylcholine binding protein (AChBP), first identified in 
Lymnaea stagnalis, has been described and characterised (Brejc et a l , 2001). The 
AChBP is a water-soluble protein which has clear amino acid sequence similarity 
to the nAChR extracellular domain. It forms a soluble homo-pentameric protein 
that is thought to be involved in suppression of cholinergic transmission by 
binding acetylcholine. The AChBP has been crystallised and its structure 
determined at high resolution (2.2 A) by X-ray crystallography (Ulens et a l ,
2006). The three-dimensional structure of the AChBP was found to be 
remarkably similar to the extracellular region of the Torpedo nAChR. In addition 
to binding acetylcholine, the AChBP can also bind other nicotinic ligands such 
(+)-tubocurarine and aBTX, (Brejc et al., 2001). The AChBP has been 
successfully crystallised in the presence of the nAChR agonists nicotine and 
carbachol (Celie et a l , 2004), and of the antagonists a-conotoxin (Celie et a l , 
2005) and a-cobratoxin (Bourne et a l , 2005). Recently, a 1.94 A high-resolution 
crystal structure of the extracellular domain of the mouse nAChR a l subunit 
bound to aBTX was determined (Dellisanti et a l , 2007). The crystal structures 
have been used extensively to interpret experimental observations at the detailed
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N-terminal
Figure 1.2 High resolution structure of the nAChR. Ribbon diagrams o f  the Torpedo 
nAChR amino-acid sequence (4-TM and MA domains) and the Lymnaea AChBP (N-terminal 
domain), fitted to the density map obtained by electron microscopy, (a) V iew  o f the whole 
receptor, as seen from the synaptic cleft and (b) when rotated through 90° and viewed parallel 
with the membrane plane. Subunits are labelled in red (a), green (p), blue (y) and light-blue 
(8). (c) For clarity, a single subunit (a) is shown viewed with the central channel axis behind 
(left panel) and rotated through 90° with the channel axis to the side (right panel), (d) View o f  
the receptor channel domain, as seen from the synaptic cleft, showing the relative positions o f  
the a-helices which make up the TM domain. The M2 helix o f  each subunit lines the channel 
pore, while the helices M l, M3 and M4 separate the M2 helix from the surrounding lipids o f  
the plasma membrane, (a), (b) and (c) reprinted from Unwin 2005, with permission from 
Elsevier, (d) reprinted by permission from Macmillan Publishers Ltd. (Miyazawa, 2003).
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molecular level, providing valuable insights into nAChR binding and gating 
mechanisms.
1.4.4 The extracellular ligand-binding domain
The N-terminal extracellular domain of the nAChR is responsible for ligand 
binding. Acetylcholine binds to the nAChR ligand binding domain which results 
in a conformational change of the receptor protein complex, going from the 
‘closed’ state to an ‘open’ state, allowing cations to pass through the receptor 
channel from the extracellular side to the intracellular side of the plasma 
membrane.
As previously described, the binding sites of nAChR ligands have been mapped to 
the a-y and a-5 subunit interfaces of the fish electric organ and vertebrate muscle 
nAChRs (see Section 1.4.2). Both the a subunit and associated non-a subunits (y 
or 5) contribute to the ligand-binding domain. Evidence to support this 
conclusion has been provided by studies in which cell lines expressing a l with 
only the y or 5 subunit formed a ligand binding site with pharmacological 
characteristics similar to that of native receptors (Blount and Merlie, 1989). In 
contrast, expression of the a l subunit alone, or in combination with the pi 
subunit, failed to produce a high-affinity ligand-binding site (Blount and Merlie,
1989). These data suggest that there are two agonist-binding sites in muscle 
nAChRs. The binding sites have been termed non-equivalent (or non-identical)
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owing to the differences in binding affinities to a-y and a-8 complexes of 
antagonists such as (+)-tubocurarine (Blount and Merlie, 1989) and a-conotoxin 
MI (Sine et al., 1995). Heteromeric neuronal nAChRs containing one a-type and 
one p-type subunit (e.g. a4p2), and with a stoichiometry (a)2(p)3, are believed to 
also form two binding sites.
The a7 subunit is expected to have five equivalent binding sites and experiments 
with recovery from MLA inhibition are best fitted with a five binding site model 
(Palma et a l,  1996). It is however possible that activation of the receptor may 
only require ligand binding to two sites (Corringer et al., 1995; Servent et al.,
1997). The crystal structure of the related homomeric AChBP also supports five 
ligand binding sites per homomeric receptor. Evidence to support this conclusion 
has come from X-ray crystallography studies in which receptor structures exist 
with five ligands bound to the binding sites (Celie et al., 2004).
1.5 Assembly and trafficking
1.5.1 Folding and assembly of nAChRs
The formation of functional ligand-gated ion channels such as the nAChR is a 
complex process involving a number of stages prior to the insertion of the final 
mature protein at the cell surface (Green and Millar, 1995). The nascent linear
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protein sequence of each subunit must fold into the correct membrane-spanning 
topology and assemble with other subunits in the correct stoichiometry and 
arrangement. This occurs in the endoplasmic reticulum (ER), where the receptor 
also undergoes post-translational modifications before export through the Golgi 
apparatus to the plasma membrane (Green and Millar, 1995). Nicotinic receptors 
assemble slowly and inefficiently in comparison to other transmembrane proteins. 
This is thought to be due to inaccurate folding of the subunit proteins, which has 
been monitored by the formation of ligand binding sites and conformational 
epitopes for monoclonal antibodies (Merlie and Lindstrom, 1983).
The muscle-type nAChR has provided two models of nAChR assembly. In the 
“heterodimer” model (Blount and Merlie, 1991; Gu et a l , 1991), the a subunit 
first associates with the y and 8 subunits to form ay and a5 heterodimers. The 
heterodimers then coassemble with the p subunit creating the a2Py8  pentamer. In 
the “sequential” model (Green and Claudio, 1993; Green and Wanamaker, 1997, 
1998), the a, p and y subunits rapidly assemble into trimers. The trimer 
undergoes further post-translational folding to form an aBTX binding site, before 
the addition of the 8  subunit into an aPy8 tetramer and the subsequent formation 
of an acetylcholine binding site. Finally, the second a subunit is incorporated into 
the tetramer creating the a2PyS pentamer. Currently, evidence favours the 
sequential model o f nAChR assembly (Wanamaker et a l , 2003). Only fully 
assembled pentameric receptors are targeted for export from the ER to the Golgi 
apparatus (Gu et a l , 1991). Further post-translational modifications such as TV-
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Glycosylation and formation of the disulphide bridge to create the Cys-loop, also 
occur at this stage of assembly in the ER.
1.5.2 Post-translational modification of nAChRs
After translation of the mature mRNA transcript by ER-associated ribosomes, the 
nascent nAChR undergoes several post-translational modifications additional to 
those mentioned above (Section 1.5.1). These include the formation of disulphide 
bonds, glycosylation, palmitoylation and phosphorylation (Green and Millar,
1995).
Glycosylation, the addition of sugar units such as glycan chains to proteins, is the 
most common covalent protein modification which occurs in eukaryotic cells 
(Helenius and Aebi, 2004). Glycan chains can be added to either the amide 
nitrogen of asparagine (AMinked glycosylation), which occurs in the ER, or to the 
hydroxy oxygen of serine or threonine (0-linked glycosylation), which occurs 
primarily in the Golgi apparatus. Glycosylation can contribute significantly to the 
molecular weight of a protein and is critical in such processes as protein folding, 
assembly and function. The added carbohydrates serve as ‘tags’ for other proteins 
which act as chaperones in the ER. The extracellular N-terminal domain of the 
nAChR contains several putative sites for glycosylation. Block of TV-linked 
glycosylation in mouse fibroblasts expressing the four Torpedo nAChR subunits 
inhibits the folding and subunit assembly, and severely attenuates subsequent
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expression of receptors at the cell surface (Wanamaker and Green, 2005). A high 
resolution (1.94 A) crystal structure of the mouse nAChR a l subunit revealed an 
//-linked carbohydrate chain attached to residue Asn141 within the Cys-loop 
(Dellisanti et al., 2007). The glycan chain makes a number of contacts with the 
loop regions of the nAChR a l subunit ligand binding pocket suggesting a role for 
glycosylation in ligand binding. Since this specific glycosylation site (within the 
Cys-loop) is conserved only in muscle nAChRs and not other members of the 
nAChRs, it has been speculated that it may confer the ability to bind aBTX 
(Dellisanti et a l, 2007).
Palmitoylation, the covalent linkage of palmitate to a cysteine residue of proteins, 
is a reversible post-translational modification and has been found in over 100 
proteins to date (Resh, 2006; Linder and Deschenes, 2007). Palmitate is a 16- 
carbon saturated fatty acid and a common acyl residue of membrane 
phospholipids. Palmitate, from palmitoyl-CoA, is attached to proteins via a 
thiester (S-acyl) linkage by membrane-associated protein acyltranferases (PATs) 
in the forward reaction; and cleaved by cytoplasmic acylprotein thioesterases 
(APTs) in the reverse reaction. Palmitoylation has been found to play an 
important role in trafficking of proteins to the plasma membrane, and in the case 
of membrane-spanning proteins, to specific plasma membrane domains such as 
lipid-rafts (Salaun et al., 2005). Lipid rafts have been found to co-localise with a7 
nAChRs and are required for the maintenance of a7 clustering in the somatic 
spines of ciliary neurones (Bruses et al., 2001). Palmitoylation has also been
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implicated as a factor important in the successful expression of a7 nAChRs at the 
cell surface. In cell lines such as HEK-293, which are non-permissive to a7 
expression, receptors are not significantly palmitoylated. In contrast, in PC 12 
cells, which do allow a7 expression, receptors show significant palmitoylation 
(Drisdel et al., 2004).
Phosphorylation, the addition of phosphate groups to hydroxyl groups of proteins 
on serine, threonine or tyrosine side chains, modulates the functional properties of 
many cellular proteins, including nAChRs (Swope et al., 1999; Wiesner and 
Fuhrer, 2006). In particular, the M3-M4 intracellular loop domain contains 
potential phosphorylation sites, as determined by the presence of protein 
phosphorylation consensus sequences. Tyrosine kinases can phosphorylate the p, 
y and 5 subunits of the Torpedo nAChR (Huganir et a l,  1984), while cyclic AMP 
(cAMP)-dependent protein kinase A (PKA) phosophorylates y and 5 subunits 
(Huganir and Greengard, 1983). Protein kinase C (PKC) can phosphorylate the a 
and 8 subunits and affect the rate of desensitisation and channel conductance 
properties (Eusebi et al., 1987). Src-family kinases (SFK) can promote the 
clustering and stability of nAChRs at the neuromuscular junction, while the same 
kinases mediate a negative regulatory effect upon a l  cells of the CNS (Wiesner 
and Fuhrer, 2006).
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1.6 Distribution of native nAChR subtypes
Nicotinic AChRs are widely distributed throughout the CNS and PNS and their 
subunit composition is region- and cell-specific. The predominant receptor 
subtype found in the brain is the heteromeric aBTX-insensitive a4p2* nAChR 
subtype (where the asterisk denotes the possible presence of an unknown subunit; 
Lukas et al., 1999). Within the PNS, the predominant subtype is the a3p4* 
containing nAChR. Homomeric aBTX-sensitive a l  nAChRs are highly
expressed in the cortex, hippocampus and subcortical limbic regions of the brain, 
and at lower levels in the thalamic regions and basal ganglia (Gaimarri et a l ,
2007). Due to the large diversity of nAChR subunits available to form 
heteromeric receptors, characterising the different receptor subtypes within the 
brain has been problematic.
While the distribution of nAChR subunit mRNA and protein has been 
investigated, the subunit composition of all native receptors is as yet unknown. 
Some work has been done to elucidate the subunit combinations that form 
receptors in native cells, for example, in chick ganglion neurones there are 
thought to be only three populations of receptors (Conroy and Berg, 1995). In situ 
hybridisation and immunohistochemistry experiments investigated the distribution 
of specific subunit mRNA and protein, and demonstrated the differing expression 
patterns of the nAChR subunits. For example the p2 subunit mRNA is widely 
distributed throughout the brain (Swanson et al., 1987; Paterson and Nordberg,
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2000). In contrast the a2 subunit mRNA is only seen in the interpeduncular 
nucleus (Wada et a l , 1988). There is considerable overlap in the expression 
profile of many of the subunit mRNAs, suggesting that the proteins they encode 
may have the opportunity to coassemble to form a wide range of receptors.
1.6.1 Central nervous system (CNS) distribution
Ligand binding studies with [3H]ACh and [125I]aBTX have been performed in the 
brain to examine the distribution of potential neuronal nAChRs. Both these 
ligands bind to muscle nAChRs but show a differential binding pattern in the 
brain, indicating the presence of more than one distinct population of nAChR 
(Clarke et a l , 1985).
The a4 and 02 subunit mRNAs and proteins are widely expressed in the central 
nervous system (Goldman et a l,  1987; Swanson et a l,  1987; Deneris et a l,
1988). They form functional heteromeric receptors when expressed 
recombinantly (Boulter et a l,  1987; Buisson et a l,  1996) with high affinity to 
nicotine (Connolly et a l,  1992). Immunodepletion experiments in chick brain 
have shown that a large proportion of the epibatidine binding receptors contain a4 
and 02 (Conroy and Berg, 1998). These two subunits probably form the primary 
site for high affinity nicotine binding in the central nervous system (Zoli et a l,
'i
1998). Both a4 and 02 knockout mice lack high affinity [ H]-nicotine binding 
sites (Picciotto et a l,  1995; Marubio et a l,  1999).
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Additional subunits combine with the a4p2 receptor to form diverse receptors in 
the central nervous system. The a5 subunit has been shown to assemble with a4 
subunits in the brain (Conroy et al., 1992). The p3 and p4 subunits have been 
shown to co-assemble with a4p2 in rat cerebellum (Forsayeth and Kobrin, 1997). 
However, there are also nAChRs that contain no p2 subunit. When the p2 subunit 
is knocked out there are still high affinity [3H]-epibatidine sites in the dorsocaudal 
medulla oblongata, pineal gland and habenula-ventral interpeduncular system, 
which are consistent with the pharmacology of a3p4 (Zoli et al., 1998).
Radioligand binding of [125I]aBTX in the brain is thought to be due to a7 
nAChRs. The localization of a l  mRNA has been shown to overlap with 
[125I]aBTX binding sites (Seguela et al., 1993) and a l  knockout mice lack aBTX 
binding. Nicotine induced currents in rat hippocampal slices that are blocked by 
aBTX and MLA are not present in the knockout mice (Orr-Urtreger et a l , 1997). 
The radioligand [ I]aBTX also binds to the a8 subunit, however, this subunit has 
only been identified in avian species (Schoepfer et al., 1990). The a l  homomeric 
receptors are thought to account for about 74% of aBTX binding sites in chick 
brain (Keyser et al., 1993). A recent summary of the data on nAChR subtype 
location in the rodent brain is shown in Figure 1.3.
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VFigure 13  Distribution of nAChR subtypes in the rodent central nervous system.
Evidence for receptor subtytpes comes from the amalgamation o f data obtained from 
radioligand binding, immunoreactivity, in situ hybridisation and single-cell PCR studies, from 
wild-type and knockout mice. An asterisk denotes the possible presence o f  an unidentified 
subunit within the receptor. Reprinted from Gaimarri et al., 2007, with permission from 
Elsevier.
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1.6.2 Peripheral nervous system (PNS) distribution
Little or no a4 subunit is expressed in the periphery (Rust et a l,  1994). In 
contrast, the a3 and p4 transcripts are highly expressed and thought to be the 
primary high affinity nicotinic receptors in the periphery (Corriveau and Berg, 
1993; Mandelzys et a l,  1994). The a3 subunit has been shown to co- 
immunoprecipitate with the p4 subunit in the rat trigeminal ganglion (Flores et a l, 
1996). In addition, there is evidence that other subunits can co-assemble with 
some a3p4 nAChRs, including a5 and p2 in the chick ciliary ganglion (Vernallis 
et a l,  1993; Conroy and Berg, 1995) and the rat trigeminal ganglion (Flores et a l,
1996). The a6 and p3 subunits were also shown to assemble with a3p4 in the 
chick retina (Vailati et a l, 2000).
[125I]aBTX binding sites are seen in cultured sympathetic neurones (Patrick and 
Stallcup, 1977b; Carbonetto et a l, 1978), and nAChR a7 subunit mRNA is 
highly expressed in the rat superior cervical ganglion and adrenal medulla (Rust et 
a l,  1994) and also in the chick ciliary ganglion (Corriveau and Berg, 1993). In 
both rat and chick there are thought to be at least three receptor subtypes that may 
contain the al subunit due to the distinct pharmacological subtypes that are 
sensitive to aBTX and MLA (Yu and Role, 1998; Cuevas et a l,  2000). Possible 
subunits that could assemble with al are p2 (Britto et a l,  1992) and P3 (Palma et 
a l,  1999). A splice variant of the al subunit, which forms receptors that exhibit 
different functional and pharmacological properties to the original homomeric al
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receptor has also been detected (Severance et al., 2004). This splice-variant could 
account for the aBTX sensitive receptors in the PNS showing distinct properties 
to the typical a7 subunit found in the CNS.
1.6.3 Non-CNS or PNS distribution
Responses to ACh have been detected in cochlear hair cells (Art et al., 1984), yet 
most nAChR subtypes are not expressed there (Hiel et al., 1996). Only the a9 and 
alO nAChR subunits are expressed in cochlear hair cells, with their expression 
generally restricted to the peripheral vestibular system and are thought to mediate 
the auditory response (Elgoyhen et al., 1994; Elgoyhen et al., 2001). The a9al0  
nAChR has also been found expressed in dorsal root ganglion (DRG) neurones 
(Lips et a l,  2002). Homomeric a9 and heteromeric a9al0  nAChRs, characterised 
upon expression in Xenopus oocytes, exhibit a pharmacological profile unique 
among nAChRs. Consistent with their distinct localisation, nAChRs containing 
a9 and alO do not fall conveniently into the conventional classification of either 
muscle-type or neuronal-type nAChRs (Elgoyhen et al., 1994; Rothlin et al., 
1999; Verbitsky et al., 2000; Elgoyhen et al., 2001). Recently a9al0  receptors 
have been identified in a variety of other tissues, where their role is less well 
defined, such as lymphocytes, sperm, and keratinocytes, and have been implicated 
in mediating process such as neuropathic pain and aspects of the immune response 
(Vincler et al., 2006). The nAChR a l  subunit has also been found in macrophage 
cells of the immune system where it is regulates inflammation (Wang et al.,
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2003). Messenger RNA levels of other nAChRs subunits are present in multiple 
cell types of the intestine (Glushakov et a l , 2004), although at present, the role of 
nAChRs found outside the CNS and PNS remains largely unclear (Gahring and 
Rogers, 2005).
1.7 Aim of study
The main aim of the present study is to undertake a detailed comparison of 
intracellular loop domains from different nAChR subunits. This has been 
achieved by the construction of a series of subunit chimaeras containing a 
common extracellular domain (from the nAChR a l  subunit) and transmembrane 
domains (from the 5 -HT3A subunit), but with different nAChR intracellular loop 
domains.
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Chapter 2 
Materials and Methods
2.1 Materials
All chemicals were obtained from BDH unless otherwise specified. All restriction 
enzymes and restriction enzyme buffers were obtained from Promega unless 
otherwise stated. A Biofuge 13 (Heraeus Instruments) was used to centrifuge 
samples unless otherwise specified.
2.2 Plasmids
Rat a l-a7  and pl-p4 nAChR subunit cDNAs were obtained from Dr. Jim Patrick 
(Baylor College of Medicine, Houston, USA). The rat a7 cDNA had previously 
been excised and subcloned (Gee et a l , 2007), into the Hindlll/Xhol sites of the 
plasmid vector pZeoSV2+ (Invitrogen). Rat a9-al0  nAChR subunit cDNAs were 
obtained from Dr. Belen Elgoyhen (Universidad de Buenos Aires, Buenos Aires, 
Argentina). Chick a8 nAChR subunit cDNA was obtained from Dr Jon 
Lindstrom (University of Pennsylvania, PA, USA). Chick a8 subunit cDNA was 
subcloned from pBluescript SK- (Stratagene) and subcloned into pcDNA3neo in
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this laboratory by Dr Sandra Cooper (Cooper and Millar, 1998). The mouse 5- 
HT3A subunit cDNA in pCDM6 xl was obtained from Dr David Julius, 
(University of California, CA, USA) and subcloned into pZeoSV2+ (Invitrogen) 
in this laboratory by Dr Sandra Cooper (Cooper and Millar, 1998). Human 5- 
HT3B in pCDM8 was obtained from Dr Ewen Kirkness (Institute for Genomic 
Research, Rockville, Maryland, USA). Human RIC-3 cDNA was isolated and 
subcloned into pcDNA3neo in this laboratory by Dr Anne Doward (unpublished). 
All subunit cDNAs or chimaeric constructs in this study were in the expression 
vector pZeoSV2+ unless otherwise stated. Human RIC-3 constructs were in 
pcDNA3neo.
2.3 Molecular biological techniques
2.3.1 Construction of subunit chimaeras
t r < \ / \  |  C T I T 1  A
The construction of a subunit chimaera (a7 ' ) containing regions of the rat
nAChR a7 subunit extracellular domain and the mouse 5 -HT3A subunit 
transmembrane (TM) and intracellular domains has been described previously 
(Cooper and Millar, 1998), as has a related chimaera (a74™‘5HT3A), in which the 
5 -HT3A intracellular loop domain has been replaced with the equivalent region of 
the a7 subunit (Gee et a l , 2007). Unique endonuclease restriction enzyme sites 
(.Notl and BstZ 171) were introduced at the N- and C-terminal ends of the large
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M3-M4 intracellular loop domain of a 7 4™*5HT3A by use of the QuikChange site- 
directed mutagenesis, polymerase chain reaction (PCR) system (Stratagene), to 
create ay4™ -^737^ 01785^  The Notl site was introduced at a position in a74™' 
5HT3A eqUivaient Met308 of Torpedo californica nAChR a l subunit (as 
determined by protein sequence alignment using the ClustalW algorithm; 
Mac Vector, Accelrys), and numbered according to the a l subunit sequence minus 
the predicted signal peptide (Noda et al., 1982). Similarly, the B stZ lll site was 
introduced to a 74™-5HT3A at a position equivalent to Met404 of the T. californica 
nAChR a l subunit.
To generate the series of ‘loop chimaeras’, the M3-M4 intracellular loop domain 
was amplified by polymerase chain reaction (PCR) using the high-fidelity 
polymerase KOD (Novagen). Sequences were amplified from nAChR and 5- 
HT3R subunit cDNA construcst with primers designed to introduce Notl and 
B stZ lll  sites. Fragments were amplified from rat nAChR subunit cDNA clones, 
with the exception of a8 which has not been identified in mammalian species and 
was amplified from chick cDNA. In the case of the 5-HT3R subunits 3 A and 3B, 
fragments were amplified from mouse cDNA clones. After digestion with Notl 
and B stZ lll  (New England Biolabs), PCR fragments were ligated into the Notl 
and B stZ lll  sites of ay4™ -^73^ 0178^  All plasmid constructs (in the mammalian 
expression vector pZeoSV2+; Stratagene) were verified by nucleotide sequencing. 
The series of nAChR subunit M3-M4 intracellular loop domain chimaeras will be 
referred to as a7/5-HT3Aal’loop (etc.) or, more simply, as ‘a l loop’ chimaera (etc.).
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2.3.2 Polymerase chain reaction (PCR)
One of two DNA polymerase enzymes was employed: Taq (Promega) was used 
for standard diagnostic PCR reactions and KOD (Novagen) was used for high- 
fidelity PCR where DNA fragments were required for further cloning (e.g. M3- 
M4 loop regions). PCR amplification was performed in a Peltier thermal cycler, 
PTC-225 (MJ Research). A typical reaction was performed in 20 pi and 
contained 200 ng of plasmid DNA, 0.25 pM forward and reverse synthetic 
oligonucleotide primers (obtained from Sigma-Genosys), 250 pM dNTPs, lx 
polymerase buffer plus MgCh (for Taq only) or MgS0 4  (for KOD only), and 2.5 
U of appropriate DNA polymerase enzyme. PCR thermal conditions were defined 
by the respective manufacturer’s instructions for each DNA polymerase enzyme.
r a l  N o t l  ( +)  
r  a l  B s t Z  ( - )
ATAAGAATGCGGCCGCTGCCCGAGTGGGTGCGGAAGG
GGGCATTCGTATACAGGCGACATACTTCCACTCCTCAGACGC
r a2 N o t l  ( + ) 
r  a2 B s t z  ( - )
ATAAGAATGC GGC C GC TGC C CAAC TGGGTAAGGGTAGC 
GGGCATTCGTATACAGGCCACATACTTCCAGTCTTCCTTCACCG
r  a3 N o t l  ( +)  
r  a3 B s t Z  ( - )
ATAAGAATGCGGCCGCTGCCCACTTGGGTCAAGGCC
GGGCATTCGTATACAGGCAACGTACTTCCAATCATCTTGAATC
r  a4 N o t l  ( +)  
r  a4 B s t z  ( - )
ATAAGAATGCGGCCGCTGCCCGCCTGGGTGCGTAGAG
GGGCATTCGTATACAGGCCACGTATTTCCAGTCCTCCTTCAC
r a5 N o t l  ( +)  
r  a5 B s t z  ( - )
ATAAGAATGCGGCCGCTGGCGCCCTGGGTTCGTAAG
GGGCATTCGTATACAGGCTATGAATTTCCAATCTTCAACAACC
r a6 N o t l  ( + ) 
r  a6 B s t z  ( - )
ATAAGAATGCGGCCGCTGCCCAAGTGGGTGAAGACC
GGGCATTCGTATACAGGCCATGTATTTCCAGTCATCTTCTACC
r a7 N o t l  ( +)  
r  a7 B s t z  ( - )
ATAAGAATGCGGCCGCTGCCTAAGTGGACCAGAATC
GGGCATTCGTATACAGGCTGCAAACTTCCATTCACTGC
r  a8 N o t l  ( +)  
r  a8 B s t z  ( - )
ATAAGAATGCGGCCGCTGCCCAGATGGGTCCGTG
GGGCATTCGTATACAAGCTGCAAACTTCCACTCACTGC
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r a 9  N o t l  ( + ) 
r  a 9  B s t z  ( - )
ATAAGAATGCGGCCGC TGC CACAC TGGGC CAAGGTG 
GGGCATTCGTATACAGGCGACCTTCTTCCACTCGCTGCC
r a l O  N o t l  ( +)  
r a l O  B s t z  ( - )
ATAAGAATGCGGCCGCTGCCCGCCTGGGCTCGGGTTC
GGGCATTCGTATACAAGCCAGACGCTTCCAATCTTCGTGGCG
r (31 N o t l  ( + ) 
r  (31 B s tz  ( - )
ATAAGAATGCGGCCGCTGCCCTTTTGGGTCCGCC 
GGGCATTCGTATACAGGC GACAAAC TGC CAGTC C TC C
r (32 N o t l  ( + ) 
r (32 B s t z  ( - )
ATAAGAATGCGGCCGCTGGCCCCCTGGGTCAAGGTG
GGGCATTCGTATACAGGCAACGTATTTCCAGTCCTCCCTCACAC
r (33 N o t l  ( + ) 
r (33 B s t z  ( - )
ATAAGAATGCGGCCGCTGGCCCCCTGGGTGAAGAGG
GGGCGGGCGTATACAAGCCACAAATTTCCAGTCTTGCAC
r |34 N o t l  ( + ) 
r  (34 B s t z  ( - )
ATAAGAATGCGGCCGCTGGCATCCTGGGTCAAGGAGTG
GGGCGGGCGTATACACGCGACGAACTTCCAGTCCTCG
m 5-HT3A N o t l  ( + ) 
m 5 -HT3a B s t Z  ( - )
AGAAGAATGCGGCCGCTACCTGACTGGCTGAGGCACC 
GAGCAGGCGTATACATC C CAC C C GCAGC CAGTCCC
h 5 -HT3b N o t l  ( + ) 
h 5 -HT3b B s t Z  ( - )
ATAAGAATGCGGCCGCAGCCCTTCTTGTGCCTTCGAGGG
GGGCATTCGTATACACAGGAGGACCAGCCACTCTGCCTC
Table 2.1 O ligonucleotide prim ers used to introduce restriction sites by PCR. Primer 
pairs used to introduce the restriction endonuclease sites Notl  and B s tZ l l l  to the M3 and M4 
ends o f  the M3-M 4 intracellular loop o f  nAChR and 5-HT3R subunit sequences. Bold type 
indicates the introduction to the sequence o f  the restriction sites Notl  (G C G G C C G C ) and 
B s tZ l l l  (G TA TA C ). A ll primers are displayed in a 5 ’ to 3 ’ direction (left to right), with (+) 
indicating a forward-facing primer and (-) indicating a reverse-facing primer. r=rat; m=mouse; 
h=human.
2.3.3 Site-directed mutagenesis
Site-directed mutagenesis (SDM) was performed using the QuikChange site- 
directed mutagenesis kit (Stratagene) using the manufacturer’s instructions. Two 
complementary synthetic oligonucleotide primers (typically of length 25-45 bases 
in length) were designed, containing the desired mutation. Oligonucleotide
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primers were designed, where possible, so the GC base content (% GC) was > 
40% and the melting temperature (Tm) was > 78 °C, as determined using 
MacVector software (Accelrys). Primers were designed to terminate in a 3’ G or 
C base and were PAGE (polyacrylamide gel electrophoresis)-purified by the 
supplier (Sigma-Genosys).
Site-directed mutagenesis reactions were performed in a volume of 50 pi 
containing 50 ng of template DNA, 125 ng each of the complementary 
oligonucleotides, 1 pi of dNTP mix (from kit), lx  reaction buffer and 1 pi of 
P/wTurbo DNA polymerase (2.5 U/pl). The reaction was heated to 95 °C for 30 
seconds and then the thermocycling reaction was performed for 12-18 cycles 
(depending on the number of mutated residues), as follows:
95 °C for 30 seconds (denaturation)
55 °C for 1 minute (annealing)
68 °C for 1 minute/kilobase of plasmid length (extension).
The reaction mixture was cooled to 4 °C and 1 pi of the restriction enzyme Dpn I 
(10 U/pl) was added and transferred to 37 °C for 1 hour to digest the methylated, 
non-mutated parental template DNA. Bacterial cells were then transformed with 
the DNA product. 1 pi of digested DNA was mixed in a pre-chilled polypropylene 
tube (Falcon 2059, Becton Dickinson) with 50 pi supercompetent XL 1-blue E. 
coli cells (Stratagene) and incubated on ice for 30 minutes. Cells were then heat
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shocked at 42 °C for 45 seconds, returned to ice for 2 minutes and then incubated 
in 500 pi of NZY4" broth, prepared according to the manufacturers guidelines, 
containing 10 g/1 NZ amine (casein hydrosylate enzymatic, Invitrogen), 5 g/1 yeast 
extract, 5 g/1 NaCl (pH 7.5), 12.5 ml/1 1 M MgCh, 12.5 ml/1 MgSC^and 10 ml/1 2 
M glucose, for 1 hour with shaking at 225 rpm. 200 pi of the transformation mix 
was plated onto LB agar plates containing the appropriate antibiotic and incubated 
at 37 °C overnight.
a7 4TM-5HT3A ( +  )  
a 7  4TM-5HT3A ( - )
CAGGACCTACAGCGGCCGCTGCCTAAGTGGACC
GGTCCACTTAGGCAGCGGCCGCTGTAGGTCCTG
a ?  4TM-5HT3A ( +  ) 
a7 4TM-5HT3A
GGAAGTTTGCAGC CTGTATAC TGGACAGGC TGC TGTTC C GC 
GCGGAACAGCAGCCTGTCCAGTATACAGGCTGCAAACTTCC
r p2 RXR-Del (+ ) 
r (32 RXR-Del ( - )
GCTCTTCCTGCAGCAGCCAGAGGGCGAGGCGGTTTTCTTCCG 
C GGAAGAAAAC CGCCTCGCCCTCTGGC TGC TGCAGGAAGAGC
m 5-HT3aFLAG ( + ) 
m 5-HT3aFLAG ( + )
CATTTGGCATTATTCTGACTACAAGGACGACGATGACAAGTGAGTG
GGCACAG
CTGTGCCCACTCACTTGTCATCGTCGTCCTTGTAGTCAGAATAATG
CCAAATG
Table 2.2 O ligonucleotide prim ers used for site-directed m utagenesis. Primer pairs used 
for site-directed mutagenesis (SDM )-PCR reactions to introduce restriction sites, FLAG- 
epitope tags and to remove the RXR-motif. Bold type indicates the introduction to the 
sequence o f  the restriction sites Notl  (G CG G CCG C) and B s tZ l l l  (G T A T A C ) to a7 4™-5HT3A5 
or the introduction o f  the FLAG-epitope tag sequence 
(G A C T A C A A G G A C G A C G A T G A C A A G ) to the C-terminal end o f  the 5-HT3aR subunit 
sequence. N ucleotide base changes to the original sequence, due to the introduction o f  Notl 
and Bs tZ l l l  are underlined. A ll primers are displayed in a 5 ’ to 3 ’ direction (left to right), with  
(+) indicating a forward-facing primer and (-) indicating a reverse-facing primer. r=rat, 
m=mouse. The a 7 4™ _5HT3A receptor subunit chimaera consists o f  rat and mouse cDNA
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Successful mutations were verified by nucleotide sequencing, and in cases where 
mutagenesis created a novel restriction enzyme site, by restriction enzyme 
digestion also.
2.3.4 Agarose gel electrophoresis
PCR products, digested plasmid DNA fragments and excised DNA inserts were 
separated by molecular weight by electrophoresis through either a 1% or 1.2% 
agarose gel. Electrophoresis-grade agarose (Invitrogen) was dissolved by heating 
and vigorous swirling in TAE buffer (40 mM Tris-acetate, 0.1 mM EDTA), 
allowed to cool and 0.3 pg/ml of ethidium bromide added. DNA samples were 
run along-side DNA size markers either, 1 pg of Hindlll digested phage X DNA 
(Invitrogen) or PCR markers (Promega). This enabled estimation of the size of 
the sample DNA. Samples and markers were loaded in lx  blue/orange loading 
dye (Promega). DNA was visualized by means of a UV transilluminator (UVP).
When DNA was required for subsequent purification, low melting point agarose 
was used (Invitrogen) and DNA fragments were excised after electrophoresis 
using a sterile scalpel. DNA was extracted from the agarose gel using the Wizard 
DNA clean up system (Promega). The agarose gel was melted in a hot block and 
mixed with 1ml of Wizard DNA-binding resin. DNA was isolated from the resin 
using a Wizard clean up column and washed with 2 ml of 80% isopropanol. 
Isopropanol was removed from the column by centrifugation and evaporation.
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The DNA was then eluted with 50 pi sterile pre-warmed Milli-Q (MQ) H2O and 
centrifuged for 1 minute at 13,000 rpm. 5 pi of this DNA was run on a diagnostic 
agarose gel to estimate the yield.
2.3.5 Restriction digestion of DNA
All restriction enzymes and reaction buffers were obtained from Promega unless 
otherwise specified. Reactions were typically carried out in 30 pi, containing 1-2 
pg of DNA, 5-10 U of restriction enzyme in the appropriated buffer. The reaction 
was incubated at 37 °C (unless otherwise specified) for 1-4 hours. After plasmid 
DNA was digested it was run on an agarose gel along side uncut DNA to ensure 
that the restriction enzyme had cut the DNA as expected. For double digests of 
plasmid vectors, plasmid DNA was digested by each enzyme singly with the same 
protocol and run along side on an agarose gel to ensure that both enzymes had cut 
the DNA as expected.
2.3.6 DNA ligation
Ligation was carried out in a volume of 10 pi, (containing a molar ratio of 
vector.'insert of 1:3), 0.5 U of T4 DNA ligase (Roche) and lx  T4 DNA ligase 
buffer. Ligation reactions were incubated overnight at 14-16 °C.
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2.3.7 Competent cells for transformation
XL 1-blue strain of Escherichia coli (E. coli) bacteria (Stratagene) were prepared 
as follows: cells were streaked onto a Luria-Bertani (LB) agar plate from a frozen 
(-80 °C) glycerol stock and grown overnight at 37 °C. A single colony was 
picked and used to inoculate 20 ml of LB medium [10 g/1 bacto-tryptone, 5 g/1 
yeast extract, 10 g/1 NaCl, adjusted to pH 7.0 with NaOH] and incubated 
overnight at 37 °C with shaking at 225 rpm. The culture was transferred to 500 
ml of SOB [20 g/1 peptone (DIFCO, Becton Dickinson) 5 g/1 yeast extract, 0.5 g/1 
NaCl, 2.5 mM KC1 and 10 mM MgCfe]. The culture was incubated at 37 °C with 
shaking at 225 rpm until the optical density, measured at 550 nm (OD550), reached 
0.5-0.55, indicating that bacteria were in their exponential growth phase. The 
culture was then centrifuged at 2500 rpm (Beckman J2-M1 centrifuge, JA-14 
rotor), for 15 minutes at 4 °C. The supernatant was discarded and the cells 
resuspended in 20 ml ice-cold RF1 solution [100 mM RbCl (Sigma), 50 mM 
MnCl2.4H20 (Sigma), 30 mM potassium acetate, 10 mM CaCl2.2H20, 15% w/v 
glycerol (Sigma), adjusted to pH 5.8 with 0.2 M acetic acid, filter sterilized (0.22 
pM)] and incubated on ice for a further 15 minutes. Resuspended cells were 
centrifuged at 2500 rpm for 9 minutes at 4 °C, the supernatant discarded, and the 
pellet resuspended in 3.5 ml ice-cold RF2 solution [10 mM RbCl, 10 mM MOPS 
(3-N-morpholinopropanesulphonic acid; Sigma), 75 mM CaCl2.2H20, 15% w/v 
glycerol, adjusted to pH 6.8 with 0.2 M acetic acid and filter sterilised (0.22 pM)].
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The cell solution was incubated on ice for 15 minutes before being aliquoted and 
snap frozen in a dry ice/ethanol bath and subsequently stored at -80 °C.
2.3.8 Bacterial transformation
Bacterial transformations were performed using 50 pi frozen stocks of competent 
E.coli cells prepared as described in Section 2.3.7. 1-20 ng of plasmid DNA, or 2- 
4 pi of ligation mixture was gently mixed with the cells in a Falcon 352005 
polypropylene tube (Becton Dickinson) and incubated on ice for 30 minutes. The 
DNA-cell mixture were then subjected to a heat shock at 42 °C for 90 seconds in 
a water bath and placed on ice for 2 minutes. 500 pi of SOC [SOB supplemented 
with 20 mM glucose (Sigma)] was added and this was incubated at 37 °C with 
shaking at 225 rpm for 1 hour to allow expression of the antibiotic resistance 
gene. 200 pi aliquots were plated on to LB-agar plates containing inhibitory 
concentrations of the appropriate antibiotic; 50 pg/ml ampicillin (Sigma) or 25 
pg/ml zeocin (Invitrogen).
2.3.9 Small scale preparation of plasmid DNA
LB medium (2 ml) containing appropriate antibiotic was inoculated with a single 
bacterial colony and grown overnight at 37 °C with shaking at 225 rpm. The 
bacterial culture was then transferred to a 1.5 ml microfuge tube, centrifuged at
13,000 rpm for 30 seconds and the supernatant aspirated off. Cell pellets were
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resuspended in 100 pi ice-cold solution I, containing 50 mM glucose, 25mM 
Tris.HCl, pH 8.0, 10 mM EDTA (Sigma), pH 8.0, by vortexing. 200 pi Solution 
II, containing 0.2 mM NaOH, 1% SDS, was added and carefully mixed by 
inversion. 150 pi ice cold solution III, containing 3 M potassium acetate, glacial 
acetic acid, was added and mixed carefully by inversion and stored on ice for 5 
minutes. This mixture was then centrifuged at 13,000 rpm for 5 minutes and the 
supernatant transferred to a fresh microfuge tube. 400 pi phenol:chlorophorm 
(1:1; Amresco) was added and mixed by vortexing to extract the protein from the 
sample. The mixture was then centrifuged at 10,000 rpm for 2 minutes. The top 
layer of liquid (-400 pi) was transferred into a fresh microfuge tube containing 
800 pi 100% ethanol, vortexed and centrifuged at 13,000 rpm for 5 minutes. The 
supernatant was aspirated off and the DNA pellet washed with 70% ethanol. Any 
excess ethanol remaining was evaporated by placing the un-capped microfuge 
tube into a hot block for 5-10 minute. The DNA was then resuspended in 20 pi 
autoclaved MQ H2O containing 50 pg/ml RNAse A (Roche), incubated at 37 °C 
for 30 minutes and frozen at -20 °C for subsequent analysis.
2.3.10 Large scale preparation of plasmid DNA
The plasmid purification kit, HiSpeed Plasmid Midi Kit (Qiagen) was used 
according to the manufacturer’s instructions as follows: LB medium (50 ml) 
containing the appropriate antibiotic was inoculated with a single colony or a stab 
from a glycerol stock and incubated overnight at 37 °C with shaking at 225 rpm.
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Cells were harvested by centrifugation in 50 ml polypropylene tubes (Falcon, 
Becton Dickinson) at 6,000 x g (Beckman J2-M1 centrifuge) for 15 minutes at 4 
°C. The pellet was resuspended in 6 ml ice cold buffer PI [50 mM Tris.Cl (pH 
8.0), 10 mM EDTA, 100 pg/ml RNAse A], by vortexing. 6 ml buffer P2, 
[200mM NaOH, 1% SDS], was added and mixed gently by inversion and 
incubated on ice for 5 minutes. 6 ml of chilled buffer P3, [3 M potassium acetate 
(pH 5.5)], was added and mixed gently by inversion, and incubated at room 
temperature for 10-15 minutes. The cell lysate was gently forced through a 
QIAfilter cartridge using a syringe plunger into a HiSpeed Tip, previously 
equilibrated with 4 ml QBT [750 nM NaCl, 50 mM MOPS (pH 7.0), 15% 
isopropanol, 0.15% Triton X-100], and allowed to pass through by gravity flow. 
The HiSpeed Tip was washed with 20 ml solution QC [1.0 M NaCl, 50 mM 
MOPS (pH 7.0), 15% isopropanol] and the DNA eluted with 5 ml solution QF 
[1.25 M NaCl, 50 mM Tris.Cl (pH 8.5), 15% isopropanol]. The DNA was 
precipitated with 0.7 volumes room temperature isopropanol and incubated at 
room temperature for 5 minutes. The precipitated DNA was then forced through a 
QIAprecipitator with a syringe, and the QIAprecipitator washed with 2 ml 70% 
ethanol. Air was forced through 2-3 times in succession to dry the membrane of 
the QIAprecipitator. The DNA was then eluted with 600 pi autoclaved MQ H2O. 
The eluted DNA was then centrifuged in a heated vacuum centrifuge (DNA-mini, 
Heto-Holten) set at 45 °C for 30-60 minutes in order to concentrate DNA samples 
and ensure no isopropanol carryover, which could interfere with subsequent steps.
72
The yield of the DNA preparation was determined using either a SmartSpec Plus 
spectrophotometer (Bio-Rad), or a Beckman Coulter DU 800 spectrophotometer. 
The absorbance at A,=260 nm (A260) and A,=280 nm (A280) was measured. The 
DNA concentration was determined from the absorbance measured at X=260 nm. 
A solution containing 50 pg/ml double-stranded DNA has an absorbance of 1 at 
X=260 nm, calculated assuming that the mass of a nucleotide pair in DNA is 660 
Daltons. The purity of the DNA was determined from the value of A260/A280, with 
approximately 1.8 indicating pure DNA. The DNA preparation was also run on 
an agarose gel for visualisation.
2.3.11 Nucleotide sequencing
Fluorescent-based capillary sequencing was carried out using the ABI Prism 
BigDye Terminator Cycle Sequencing Ready Reaction Kit 1.1 (ABI Applied 
Biosystems) according to the manufacturer’s instructions: The reaction was
carried out in a volume of 20 pi and contained 200-500 ng of template DNA, 3.2
pmol of sequencing primer (typically 18-22 bases in length) and 8 pi of
V "
Terminator Ready Reaction Mix (dye-labelled ddNTP terminators, unlabelled 
dNTPs, AmpliTaq DNA polymerase, MgCb and buffer). The thermocycling 
reaction was performed for 25 cycles as follows:
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96 °C for 30 seconds (denaturation)
50 °C for 15 seconds (annealing)
60 °C for 4 minutes (extension)
DNA was precipitated by the addition of 2 pi sodium acetate (pH 5.2) and 50 pi 
99% ethanol per 20 pi of sample reaction. This was incubated on ice for 15 
minutes and then centrifuged at 13,000 rpm for 15 minutes at room temperature. 
The supernatant was aspirated and the pellet washed in 500 pi 70% ethanol. 
Excess ethanol was removed by evaporation, by placing the un-capped microfuge 
tube in a hot block for 5-10 minutes. The DNA pellet was then resuspended in 10 
pi of formamide. Samples were sequenced using an ABI Prism 3100-Avant 
Genetic Analyzer (ABI Applied Biosystems). Fluorescent DNA fragments were 
run on a 50 cm capillary array using POP 6 polymer (ABI Applied Biosystems) 
and the data was extracted using 3100-Avant Data Collection Software Version
1.0 (ABI Applied Biosystems). Sequences were analysed using MacVector 7.2.2 
software (Accelrys).
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2.4 Mammalian cell line culture and transfection
2.4.1 Mammalian cell-line maintenance
A subclone of human embryonic kidney (HEK)-293 cells, tsA201 cells were 
obtained from Dr William Green (University of Chicago, IL, USA). This HEK 
cell line stably expresses a temperature sensitive SV40 large T-antigen. The 
Madin-Darby canine kidney (MDCK) epithelial cell line was obtained from Dr 
Mark Marsh, University College London. Cell lines were kept in a liquid nitrogen 
freezer (—150 °C) for long-term storage in screw-top cryotubes. Cells were kept 
in 1 ml Freezing Mix, containing 80% cell culture media, 10% heat inactivated 
foetal calf serum (FCS; Sigma) and 10% dimethylsulphoxide (DMSO).
2.4.2 Thawing cell lines
Cell lines were removed from long-term liquid nitrogen storage and the cryotube 
immediately placed at 37 °C to thaw. Cells were transferred to 15 ml 
polypropylene tubes (Falcon, Becton Dickinson) containing room temperature cell 
culture medium, mixed gently by pipette action and centrifuged at 900 rpm for 3 
minutes. The medium was carefully removed by aspiration and the cell pellet 
carefully resuspended in a further 10 ml cell culture medium and centrifuged as 
above. The cell pellet was then resuspended in 37 °C cell culture medium and 
transferred to cell culture dishes and incubated as described (Section 3.4.3)
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2.4.3 Cell culture
Mammalian tsA201 cells and MDCK cells were grown on 6 cm or 10 cm cell 
culture dishes (Coming) in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 2 mM L-Glutamax (Gibco-Invitrogen), supplemented with 10% heat 
inactivated FCS, 100 units/ml penicillin/100 pg/ml streptomycin (Gibco- 
Invitrogen), at 37 °C in a humidified incubator containing 5% CO2. Cells were 
passaged by aspiration of conditioned cell-culture medium, washing once with 4-6 
ml PBS and trypsinised with 3-4 ml trypsin:PBS (1:1) solution for 30 seconds at 
room temperature (tsA201 cells), and 10-15 minutes at 37 °C (MDCK cells). The 
trypsin:PBS solution was removed and cell culture dishes tapped vigorously to 
dislodge cells from the culture dish. Cells were resuspended in 3-5 ml fresh room 
temperature culture medium and passed through the constricted tip of a 5 ml 
pipette several times to separate cell aggregates into a homogeneous mixture of 
dissociated single cells. The cells were then re-seeded into fresh culture dishes at 
various dilutions, depending on subsequent use, and topped up with culture 
medium and maintained as described above. Cells were discarded after 25-30 
passages.
2.4.4 Transient transfection
Cells were transfected using the Effectene Transfection Kit (Qiagen) using a 
modified manufacturer’s protocol: Cells were trypsinised and re-seeded in 3 ml
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of medium (10 cm culture dish) 4-6 hours prior to transfection in order to achieve 
~ 30% confluency at the time of transfection.
For tsA201 cell transfections in a 10 cm dish, 0.6 pg of plasmid DNA was added 
to 120 pi of Buffer EC in a sterile microfuge tube and allowed to equilibriate for 5 
minutes. 4.8 pi of Enhancer (DNA condensing enhancer solution) was added, 
mixed by pipetting and incubated for 5 minutes. 13 pi of Effectene (non 
liposomal lipid formulation which coats condensed DNA with cationic lipids) was 
added, mixed by pipetting, and incubated for a further 10 minutes. 600 pi of pre­
warmed (37 °C) fresh culture medium was added, mixed by pipetting, and added 
drop-wise onto the cells making a final volume of approximately 3.7 ml (~ 5x 
final dilution of transfection mix). After 16 hours, 6-10 ml growth medium was 
added.
For MDCK cell transfections in a 10 cm dish, the same protocol as used for 
tsA201 transfection was used except a higher ratio of transfection mixture to 
medium (2:1) was used (~ 2.5x final dilution of transfection mix).
For electrophysiological studies, tsA201 cells were plated onto 13 mm glass cover 
slips (VWR international) coated with 10 pg/ml collagen and 10 pg/ml poly-L- 
lysine (Sigma) in 3.5 cm culture dishes (Falcon, Becton Dickinson), containing 1 
ml culture medium. The same transfection procedure was used as above (for
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tsA201 cells) maintaining ~5x final dilution of transfection mix. Cells were used 
24-72 hours post transfection.
2.5 Primary neuronal cultures and transfection
2.5.1 Primary hippocampal neuronal cultures
Primary hippocampal neuronal cultures were prepared from embryonic stage 18 
(E l8) Sprague Dawley rats, obtained from Biological Services (UCL). Primary 
cultures were maintained at 37 °C in a humidified incubator containing 5% CO2.
2.5.2 Isolation and culture of hippocampal neurones
Pregnant El 8 rats were euthanased by dislocation of the neck and the uterus sacs 
containing the pups quickly removed via a posterior-anterior abdominal incision 
and placed in a sterile Petri dish on ice. The pups were carefully exposed from 
their uterus sacs and quickly decapitated using sharp fine-scissors and their heads 
placed in ice-cold dissection media [15 ml lOx Hanks’ balanced salt solution 
(HBSS; Gibco-Invitrogen), 1.5 ml 1 M 4-(2-hydroxyethyl)-1-piperazine-ethane- 
sulphonic acid (HEPES; Gibco-Invitrogen), made up to 150 ml with H2O (Baxter) 
and sterile-filtered]. The brains were quickly removed, placed in fresh dissection 
medium, the hippocampi isolated by careful dissection to avoid tissue damage.
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Isolated hippocampi were then transferred to a category 2 laminar flow hood 
where they were transferred to a sterile 15 ml polypropylene tubes (Falcon, 
Becton Dickinson) containing fresh dissection medium. The volume was 
adjusted to 4.5 ml and 0.5 ml 2.5% trypsin (Sigma) added, mixed by inversion 
and incubated at 37 °C for 15 minutes in a humidified incubator containing 5% 
CO2 (with loose cap allowing access to air). The dissection medium was carefully 
replaced with fresh room temperature dissection medium, mixed by inversion and 
incubated for a further 5 minutes at room temperature. This wash step was 
repeated, after which the dissection medium was replaced with 1 ml attachment 
medium [500 ml minimum essential medium (MEM) with Earle’s salts and L- 
glutamine supplemented with 50 ml heat inactivated horse serum, 5 ml 100 mM 
sodium pyruvate/MEM, 6.6 ml 45% glucose (Gibco-Invitrogen)]. The attachment 
media containing the hippocampi were then vigorously passed through two 
consecutively reduced diameter glass Pasteur pipettes with polished tips 10-15 x 
each to achieve a homogenous solution containing dissociated neurones. Neurone 
number was calculated in a hemocytometer with erythrosine B used at a 1:4 
dilution to identify living cells. Six centimetre tissue culture dishes, containing 3 
ml 37 °C attachment medium and 13 mm glass cover slips (Assistent), pre-baked 
and coated with sterile 0.1 mg/ml poly-L-lysine (PLL) were then seeded to 
achieve a density of ~300,000 neurones per (6 cm) dish. 6-18 hours later the 
attachment medium was replaced with maintenance medium [500 ml Neurobasal 
A medium supplemented with 10 ml B27 supplement, 5 ml L-glutamine, 5 ml 100
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units/ml penicillin/100 pg/ml streptomycin and 6.6 ml 45% glucose (Gibco- 
Invitrogen)].
2.5.3 Transfection of hippocampal neurones
Neurones were transfected using a variation of a previously described calcium 
phosphate method (Jiang and Chen, 2006). Briefly, a total of 15 pg DNA was 
used to transfect each 6 cm dish. Two tubes were prepared: ‘Tube A’ containing 
375 pi 2x HBSS (pH 7.05) and ‘Tube B’ containing 15 pg total DNA and sterile 
water up to a volume of 328.5 pi to which 46.5 pi 2M CaCb solution had 
previously been added dropwise and mixed by gentle swirling. Tube A was 
gently mixed dropwise (1/8 at a time) into Tube B and the solution left to incubate 
at room temperature for 20 minutes. The DNA/transfection solution was added 
dropwise to the 6 cm dishes containing neurones in 1.5 ml fresh neuronal 
maintenance medium and incubated under standard conditions for 40-60 minutes. 
Transfection dishes were the washed 3x with 3 ml fresh maintenance media and 
then incubated with 3 ml pre-conditioned media until processing for 
immunostaining.
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2.6 Radioligand binding
Radioligand binding was performed on either intact cells (to determine levels of 
receptor expressed on the cell surface) or permeabilised cells (to determine the 
level of total cellular receptor).
2.6.1 [I25I]a-bungarotoxin and [3H]methyllycaconitine binding
Radioligands [125I]a-bungarotoxin ([125I]aBTX; specific activity 7.4 TBq mmol'1) 
and [3H]MLA (specific activity 2.2 TBq mmol'1) were purchased from GE 
Healthcare and Perkin Elmer, respectively. For both intact-cell and cell 
membrane measurements, cell monolayers were rinsed and collected in HBSS 
using a cell scraper (Corning) and pelleted by gentle centrifugation. Cell 
membranes were prepared by freeze/thawing of cell pellets and were resuspended 
in phosphate buffer containing protease inhibitors (with final concentrations of 1 
(Ltg m l'1 pepstatin, 2 ^g ml'1 leupeptin, 2 fxg ml'1 aprotinin), transferred to 5 ml 
polystyrene assay tubes and incubated with radioligand (10 nM [ IJaBTX or 
lOnM [3H]MLA) for 2 hours, shaking, on ice. In the case of aBTX binding, 1% 
bovine serum albumin was added to the assay. Non-specific binding was 
determined with 1 mM nicotine and 1 mM carbachol. For cell-surface [125I]aBTX 
binding, cells were prepared as above except, after pelleting, cells were 
resuspended by gentle agitation and pipetting, and assayed in HBSS (containing
p c  -J
protease inhibitors, as above) at room temperature. [ IJaBTX and [ HJMLA
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labelled samples were harvested using a Brandel cell harvester (Model M36, 
Semat) onto Whatman GF/A and Whatman GF/B filters, respectively, pre-soaked 
for at least 1 hour in 0.5% w/v polyethylene-imine. Radioactive counts were 
assayed in a gamma counter (Wallac 1261 Multigamma) for [125I]aBTX binding 
and by a scintillation counter (Beckman LS 6500) for [3H]MLA binding.
2.6.2 Protein assay and cell counting
The protein concentration of cell membrane preparations was determined using a 
Bio-Rad DC protein assay according to the manufacturer’s instructions. 
Typically, 20 pi of diluted sample (1/10) or bovine serum albumin (BSA) 
standard was added to a semi-microcuvette (Starstedt) and mixed with 100 pi of 
Reagent A (alkaline copper tartrate solution). 800 pi of Reagent B (a dilute Folin 
Reagent) was added, the reaction mixed by vortexing and incubated at room 
temperature for 30 minutes. Protein concentration was determined by 
measurement of the absorbance at ?t=750 nm with a spectrophotometer 
(SmartSpec Plus, Bio-Rad). Samples were compared to BSA standards at 
concentrations of 0.1, 0.2, 0.4, 0.8, 1.0 and 1.2 mg/ml.
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2.7 Metabolic labelling and immunoprecipitation
2.7.1 Metabolic labelling
To facilitate immunoprecipitation, an eight amino acid FLAG epitope tag 
(DYKDDDDK) was introduced at the extreme C-terminus of the loop chimaeric 
constructs by site-directed mutagenesis, using the QuikChange mutagenesis 
system (Stratagene, Amsterdam) and primers previously described (Table 2.2). 
Transfected tsA201 cells were metabolically labelled as described previously 
(Cooper and Millar, 1997). Briefly, after growth in methionine-free medium for 
15 min, cells were labelled with 9-12 MBq Pro-mix, a mixture of [35S]methionine 
and [35S]cysteine, (GE Healthcare) in 3.5 ml methionine-free medium for 3 hours. 
Complete medium containing 10% heat-inactivated FCS was then added and the 
cells incubated for a further 3 hours. Cells were washed twice with 6 ml 
phosphate buffered saline (PBS) and harvested into 500 pi ice-cold lysis buffer 
(150 mM NaCl, 50 mM Tris-HCl pH 8.0, 5 mM EDTA and 1% Triton-XlOO) 
containing protease inhibitors (0.25 mM phenylmethylsulfonyl fluoride, 1 mM N- 
ethylmaleimide and 2 pg/ml, each, of leupeptin, aprotinin and pepstatin). 
Solubilisation and all subsequent steps were performed at 4°C. The cell lysate 
was pre-cleared by incubation overnight with 35 pi protein G-Sepharose (GE 
Healthcare) in a 1:1 mixture with lysis buffer. Non-solubilised material was 
pelleted by centrifugation at 16,000 x g for 15 min. Cell lysates were incubated 
with primary antibody for 3 hours. The antibody-receptor complex was
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immunoprecipitated by the addition of 30 pi protein G-Sepharose, incubated for a 
further 3 h and isolated by centrifugation. Samples were washed 4 times with 1 
ml lysis buffer. Samples were examined by SDS polyacrylamide gel 
electrophoresis followed by autoradiography as described previously (Lansdell et 
a l , 1997).
2.7.2 SDS-polyacrylamide gel electrophoresis of proteins
Discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE), was carried out to separate polypeptides using an 8% resolving gel [21.1 
ml H2O, 8 ml 40% acrylamide, 10 ml 1.5M Tris (pH 8.8), 0.4 ml 10% SDS, 0.4 
ml 10% ammonium persulphate and 24 pi tetramethylethylenediamine (TEMED)] 
with a 5% stacking gel [5.8 ml H2O, 1 ml 40% acrylamide, 1 ml 1.5 M Tris (pH 
6.8), 80 pi 10% SDS, 80 pi 10% ammonium persulphate and 8 pi TEMED]. Total 
gel size was 15 cm by 20 cm and 0.15 cm thick. The electrophoresis apparatus 
was assembled and Tris glycine running buffer (25 mM Tris, 250 mM glycine and 
0.1% SDS) was added to the upper and lower reservoirs. Protein samples were 
resuspended with loading buffer [final concentration of constituents: 50 mM Tris- 
HC1 (pH 6.8), 2% SDS, 0.1% bromophenol blue, 10% glycerol and 100 mM 
dithiothreitol for reducing conditions]. Broad range Rainbow coloured markers 
(Promega) and [14C] methylated proteins (GE Healthcare) were used to estimate 
protein band sizes. The samples were loaded and passed through the stacking gel 
at 55 mA and then separated overnight through the resolving gel at 8 mA. The gel
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was fixed (25% methanol and 10% acetic acid) for 30 minutes, washed briefly in 
deionised H2O and soaked in Amplify (GE Healthcare) for 30 minutes. The gel 
was then transferred onto damp Whatman 3MM filter paper, covered with saran 
wrap and dried under vacuum at 80 °C (typically for 2-4 hours). The dried gel 
was then exposed to autoradiographic film.
2.8 Immunofluorescence microscopy
MDCK cells were washed three times with PBS or until loose cells and cell debris 
were removed from the cell monolayer. The polyester membrane was carefully 
excised from the surrounding support using a scalpel, marked for orientation and 
fixed in 3% PFA for 15-30 minutes. The membranes were then washed five times 
in HBSS, permeabilised with 1% Triton/HBSS, for 15-30 minutes and blocked for 
30 minutes in blocking solution containing 2% BSA/5% FCS/1% Triton/HBSS. 
Cells were incubated for two hours at room temperature, or overnight at 4°C in 
blocking solution containing Alexa-488 a-bungarotoxin (Gibco-Invitrogen) and 
DECMA-1 rat monoclonal antibody against E-cadherin, (U3254; Sigma-Aldrich). 
Cells were washed five times in HBSS, re-blocked for 30 minutes, then incubated 
for one hour at room temperature, or overnight at 4°C in blocking solution 
containing rhodamine-conjugated goat-anti-rat IgG secondary antibody (31680; 
Pierce). Cells were washed five times in HBSS, once in water and then mounted 
under glass in FluoSave (Calbiochem) mounting fluid, with the apical cell surface
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facing upwards. Confocal images were obtained with a Zeiss LSM 510 Meta 
confocal microscope and LSM acquisition software. Images were processed 
using Volocity image analysis software (Improvision). For immunofluorescent 
labelling of tsA201 cells and hippocampal neurones, treatment was the same as 
with MDCK cells, except as where specified, mAb 1234A (Peng and Froehner, 
1985) against Rapsyn was used and Rhodamine conjugated a-bungarotoxin 
(Molecular Probes) was used. Hippocampal neurones were examined with a Zeiss 
Axiophot microscope using appropriate oil-immersion objectives.
2.9 Intracellular calcium assay
Transfected cells were re-plated onto pre-coated poly-L-lysine (PLL)-coated 
black-walled 96-well plates (Marathon. Laboratories) 18-20 hours post 
transfection. Approximately 24 hours after plating, the culture medium was 
removed and cells washed with lx  100 pi HBSS per well and then incubated in 50 
pi of 1 pM Fluo-4-acetoxymethyl (Fluo-4-AM) ester (Invitrogen-Molecular 
Probes) in HBSS containing 0.02% Pluronic F-127 (Invitrogen-Molecular Probes) 
for 45-60 minutes at room temperature and in the dark. Cells were rinsed 2x 160 
pi HBSS per well and assayed using a Fluorometric Imaging Plate Reader 
(FLIPR; Molecular Devices) in 160 pi high calcium buffer (HCB; HBSS 
supplemented with 18.8 mM CaCL, 8.8 mM sucrose and 6.3 mM HEPES). Cells 
were excited at A,=488 nm and the emitted fluorescence passed through a 510 to
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570 nm bandpass interference filter before detection with a cooled CCD camera. 
A range of 1, l-dimethyl-4-phenylpiperazinium (DMPP) agonist concentrations 
(5X) were prepared in HCB in a separate a 96-well plate (Sarstedt) and 40 pi 
delivered, via an automated 96-tip pipettor, to the corresponding well of the cell- 
plate containing 160 pi HCB. Different drug concentrations were typically 
repeated in triplicate. Fluorescence measurements were recorded simultaneously 
for all 96 wells at one-second intervals, for 120 seconds in total, with continuous 
agonist addition after 25 seconds and values expressed as arbitrary fluorescence 
units.
FLIPR data was analysed with Microsoft Excel and GraphPad Prism software. 
The value for the agonist-induced response at each time-point was divided by the 
lowest value before agonist application to normalise the data. Peak responses 
were calculated from the mean of triplicate samples and the results from mock- 
transfected (empty vector) cells on the same 96-well plate, which acted as a 
negative control, were subtracted from positively transfected cells. Results were 
averaged over > n- 3 independent experiments. Data plots and dose-response 
curves were created and fitted with the appropriate equations in Graph Pad Prism 
software.
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2.10 Electrophysiological recording
HEK tsA201 cells, grown on glass cover slips coated in collagen and poly-L- 
lysine, were co-transfected with pEGFP-C2 (Clontech), encoding enhanced green 
fluorescent protein, and plasmids containing either wild type or chimaeric subunit 
cDNA in the ratio of 1:10.
2.10.1 Whole-cell patch-clamp recording
Whole-cell recordings were performed at room temperature, 24-72 hours after 
transfection using cells that were identified as expressing GFP by fluorescence 
microscopy. Recording solution contained (in mM): 110 NaCl, 5.4 KC1, 0.8 
MgCE, 1.8 CaCE, 25 glucose, 0.9 NaFEPC^, 44 NaHCC>3. Borosilicate electrodes 
(GC150F-7.5; Harvard Apparatus) of resistance 4-8 MD contained (in mM) 140 
CsCl, 10 HEPES, 10 EGTA, 0.5 CaCl2, 29.53 CsOH, pH adjusted to 7.26. The 
holding potential was -60 mV. Fast cell superfusion was achieved with a theta- 
barrelled application pipette made from 1.5 mm diameter theta tubing (AH-30- 
0114; Harvard Apparatus), which was moved laterally using a stepper motor. 20- 
second applications of 50 pM DMPP were applied and evoked currents recorded 
using an Axopatch 200B amplifier. These were digitised online at 10 kHz using 
the software WinEDR (Strathclyde Electrophysiology Software; 
www.strath.ac.uk/Departments/PhysPharm) after filtering and further
amplification to provide a low-gain 0 Hz-2 kHz record that was used to measure 
the agonist-induced mean current.
2.11 Desensitisation analysis
The kinetics of desensitisation were analysed on 20 second agonist applications. 
Responses were inverted and fitted with a single exponential or the sum of two 
exponential functions:
I(t)=SS+Imax. ew  [single] or I(t)=SS+Imaxi . e (,/ll> + Imax2. [double]
Where t is the whole cell current, Imax is the peak of the whole cell current, SS is 
the steady state current, t is the time after the peak of the whole cell current and x 
is the time constant of desensitisation. The fit of a single or double exponential 
was performed by inverting the current and fitting to the appropriate function 
using Prism software (GraphPad). Thus the time constants (x) and relative 
amplitudes for double exponential function and the steady state desensitisation 
were obtained. Where a double exponential fit was used, a weighted time 
constant was calculated by multiplying each time constant by the proportion of its 
starting amplitude.
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2.12 Conductance estimation from noise analysis
A high-gain bandpass (2 Hz-2 kHz butterworth filter) recording was used for 
variance and spectral density analysis. The recording was divided into segments 
of 0.82 seconds duration and edited to remove any segments with obvious 
artefacts.
2.12.1 Noise variance analysis
The relationship between the variance and the single-channel current can be 
derived from the binomial theorem, assuming that channels open independently 
from one another (Traynelis and Jaramillo, 1998). For a cell with N channels that 
have a single-channel current of i, the mean current (I) is equal to:
I=iNp
where p is the probability that the channel is open. The current variance (0^1) is 
equal to:
or2 i=i2Np(l-p)
When this is rearranged and N is substituted for: 
crVilO-p)
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This means that when p is small (<0.1) then the variance is directly proportional 
to the mean current, with the single-channel current as the constant of proportion. 
The variance (after subtraction of baseline variance) of each high gain AC 
segment was determined and plotted against the mean current (after subtraction of 
baseline current) of the equivalent low gain DC segment. This was then fitted 
with a straight line (y=ix+c; where c was constrained to 0) by linear regression, 
and the single-channel conductance derived from the slope of the line (i), divided 
by the holding potential of the recording (-60 mV in this case).
2.12.2 Noise power spectral density analysis
The relationship between the variance of the current fluctuations and the kinetics 
of receptor activation was examined by generating a power spectrum. The 
objective was to show how energy (amplitude squared per frequency) is 
distributed across the frequencies of the variance.
A 10% cosine taper window was applied to each segment and the single-sided 
spectral density computed by fast Fourier transform and averaged over 96 
logarithmically spread frequency ranges. The mean background spectrum was 
subtracted from the mean spectrum in the presence of the agonist to give the net 
agonist-induced noise spectrum. The single channel conductance was calculated 
from the variance of the noise and from integration of the net power spectrum
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fitted with a single or the sum of two Lorentzian components as appropriate 
(Dempster, 2001):
G(f)=S(0/ 1 +(f/fc)2 [single] or G(f)= S(0)l/ l + ( ^ i ) J+ S(o)2/l+(f/fc2)2
Where t is the spectral density, S(o) is the asymptotic spectral density at zero 
frequency, f  is frequency and fc is half power frequency. The time constant 
T=l/(27tfc) is an estimate of the mean single channel burst length (reviewed by 
Traynelis and Jaramillo, 1998). For two-component spectra a weighted noise time 
constant was calculated from xw = x\A\ + T2A2 where Ai and A2 are the relative 
areas of each Lorentzian component. The number of Lorentzian equations used to 
fit the data does not reflect the number of conductance states or the likely number 
of kinetic states in the receptor activation mechanism. The single channel 
conductance, y, was calculated from:
y=S(o/4Im(V-Vrev)
Where Im is the mean current, V is the holding potential and Vrev is the reversal 
potential of the receptor.
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2.13 Data manipulation and statistical analysis
All statistical analysis was performed in Microsoft Excel and GraphPad Prism 
software, with a minimum significance level of p<0.05. For multiple 
comparisons, ANOVA (analysis of variance) was used and significances 
calculated using the Tukey-Kramer post-test allowing for unequal sample sizes. 
As ANOVA assumes equal variances, Bartlett’s test was employed to determine if 
differences in variances between groups of data were significant. In those cases 
where significant differences were observed, the raw data was transformed by 
converting values to their logarithms to equalise the variances and make the 
distribution more Gaussian. ANOVA is less robust when analysing non-Gaussian 
distributed values from small sample sizes (<12 or so) and with unequal number 
of samples, which was the case here.
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Chapter 3
Characterisation of nAChR loop chimaeras
3.1 Introduction
As discussed in the Introduction (Chapter 1), individual nAChR subunits adopt a 
complex membrane topology, comprising a large extracellular N-terminal agonist- 
binding domain, four a-helical transmembrane domains (M1-M4), and a large 
intracellular loop of variable length between M3 and M4 (Green and Millar, 
1995). Previous studies have indicated that this intracellular loop domain of 
nAChRs is important for interaction with intracellular proteins (Jeanclos et a l, 
2001; Huebsch and Maimone, 2003), receptor targeting (Williams et a l , 1998; Xu 
et al., 2006) and ion channel properties (Kelley et a l,  2003; Hales et a l,  2006; 
Gee et a l, 2007).
Most nAChR subunits form only heteromeric complexes in which a subunits must 
co-assemble with at least one other type of subunit to generate a functional 
receptor. A well-characterised example is the nAChR expressed in the adult 
neuromuscular junction which is assembled from four different subunits (two 
copies of the a l subunit co-assembled with a single copy of each of the pi, 6 and
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s subunits). Similarly, most nAChRs expressed in the nervous system (neuronal 
nAChRs) are heteromeric complexes (Le Novere and Changeux, 1995; Millar, 
2003; Alexander et a l , 2007). There are a few examples of nAChR subunits 
which are able to generate functional homomeric receptors, notably a7, a8 and a9 
(Couturier et al., 1990; Elgoyhen et al., 1994; Gerzanich et a l , 1994). However, 
in each case, there is evidence that these subunits are also able to form 
heteromeric complexes in at least some species (Keyser et a l , 1993; Gotti et a l , 
1994; Elgoyhen et a l , 2001). As a consequence of the propensity of nAChR 
subunits to assemble into heteromeric complexes, it can be difficult to examine 
the influence of individual subunits (or individual subunit domains) in isolation. 
To examine the influence of intracellular loop domains from individual subunits 
independently, a series of subunit chimaeras has been constructed and 
characterised.
Subunit chimaeras have been constructed, each containing a common 
extracellular, agonist/antagonist binding domain from the nAChR a l  subunit and 
the transmembrane domains of the 5-HT3A subunit, and the variable intracellular 
(M3-M4) loop domain from all vertebrate neuronal nAChR subunits (a2-al0 and 
P2-P4) and from the muscle nAChR a l and pi subunits. By constructing an 
extensive series of related subunit chimaeras containing a variety of different 
intracellular loop domains, it has been possible to examine the influence of this 
domain upon aspects of receptor assembly, targeting and function. This was 
achieved using a variety of experimental techniques including radioligand
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binding, immunoprecipitation, fluorescence confocal microscopy and whole-cell 
electrophysiology.
3.2 Design and construction of loop chimaeras
The starting point for constructing the series of ‘loop chimaeras’ (Figure 3.1) was 
a previously described nAChR/5-HT3R subunit chimaera, a 7 4™*5HT3A (Qee et al., 
2007). The a 7 4™-5HT3A chimaera contains the extracellular N-terminal 
agonist/antagonist binding domain and the M3-M4 intracellular loop domain of 
the rat nAChR a7 subunit; and the four transmembrane domains (4-TM) of the 
mouse 5-HT3A subunit. This receptor construct was in turn modelled upon the 
previously described nAChR/5-HT3R chimaera, a 7 v201’5HT3A (Eisele et a l , 1993; 
Cooper and Millar, 1998). The a7 V20I-5HT3A chimaera contains the N-terminal 
extracellular domain of the rat nAChR a l  subunit and the remaining C-terminal 
domain (4-TM domain including the M3-M4 loop domain) of the mouse 5 -HT3A
on 1subunit. The sequences were spliced together at position Val (numbered 
according to the Torpedo a l subunit). Like the native nAChR a l  and 5-HT3AR 
subunits, both a 7 V201-5HT3A an(j a74TM-5HT3A are akje tQ form functional homomeric 
ion channels (Eisele et a l , 1993; Cooper and Millar, 1998; Gee et a l, 2007). In 
contrast to the considerable problems which have been encountered in expression 
of the nAChR a l  subunit in several mammalian cell lines (Cooper and Millar, 
1997; Kassner and Berg, 1997; Rangwala et a l, 1997), a major advantage of the
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Figure 3.1 Cloning strategy and creation o f a 7 4™-5HT3A(Not/Bst) chim aera. (a) Schematic 
representation showing the membrane topology o f  the nicotinic acetylcholine receptor a l  
subunit (left panel) and related Cys-loop receptor family member the 5-HT3A subunit (middle 
panel) used to create the chimaeric receptor, a7 4™-5HT3A (right panel). Note that a7 4™-5HT3A 
contains the extracellular N-terminal domain and intracellular M3-M4 loop domain from the 
a l  nAChR, while the transmembrane regions (M l-M3 and M4) originate from the 5-HT3AR. 
(b) Cloning strategy used to create a7 4™-5HT3A(Not/Bst) Site-directed mutagenesis was used to 
insert Notl and B stZ ll l  restriction sites flanking the M3-M4 intracellular loop o f  a7 /4™-5HT3A 
to create a 7 4™-5HT3A(No,/Bst) Note the two amino acid changes, Met308—»Lys308 and 
Val405—►Iso405, resulting from the insertion o f  the Notl and BstZ ll l  sites, respectively.
a7 nAChR 5-HT3AR q 7 4tm-5HT3a
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a 7 /5 -HT3A chimaera is that it forms a functional ion channel much more 
efficiently (Cooper and Millar, 1998). All the ‘loop chimaeras’ created in this 
study contain the nAChR a7 subunit extracellular N-terminal domain, the 5- 
HT3AR subunit 4-TM domain, and variable intracellular loop domain from 16 
members of the nAChR and 5 -HT3R families. Importantly, retention of the a7 
extracellular domain in the ‘loop chimaeras’ permits detection of all subunit 
chimaeras with the a l  antagonist a-bungarotoxin (aBTX); either in radiolabelled 
form (e.g. [125I]aBTX), or conjugated to a fluorescent tag (e.g. Alexa-488 aBTX).
Unique Notl and B stZ lll restriction endonuclease sites were introduced, by site- 
directed mutagenesis, to the a 7/5 -HT3A chimaera a74™'5HT3A, to create a74™' 
5HT3A(Not/Bst) ( p j g U re  3 ppg p[otj S[^ Q was introduced after the third
*jno
transmembrane domain (M3), at position Met and the B stZ lll  site was 
introduced before the fourth transmembrane domain (M4) at position Cys404 
(corresponding to residues Met308 and Met404 of the Torpedo nAChR a l subunit, 
respectively; Noda et a l , 1982). The restriction sites were selected based on the 
positional requirements (flanking the loop), while keeping the number of 
nucleotides altered to a minimum and avoiding any residue changes that could be 
predicted to alter the protein drastically.
Compatible Notl and B stZ lll restriction sites were introduced to the equivalent 
sites (determined by protein sequence alignment), either side of M3-M4 
intracellular loop region, of the vertebrate neuronal type nAChR subunits (a2-al0
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and (32-04), the muscle type nAChR subunits (a l and 01), and of the 5-HT3B 
subunit. The Notl and B stZ lll restriction sites were incorporated to the 
oligonucleotide primers used to amplify the M3-M4 intracellular loop segments 
during a standard high-fidelity polymerase chain reaction (PCR). All the loop 
segments were amplified from rat cDNA clones, except in the case of the nAChR 
a8 subunit, which was amplified from chick cDNA and the 5 -HT3B subunit which 
was amplified from human cDNA. The relative lengths of the M3-M4 
intracellular loop domain is highly variable between subunits and consists of 
between 78 and 143 amino acids in most cases, except for the nAChR a4 subunit 
which is 259 amino acids in length (Figure 3.2). The intracellular loops were then 
ligated into the aj 4™-5m3A(Not/Bs0 construct following appropriate digestion with 
Notl and B stZ lll restriction enzymes. The series of nAChR and 5 -HT3R subunit 
M3-M4 intracellular loop domain chimaeras will be referred to as a7/5-HT3Aal"Ioop 
(etc.) or, more simply, as ‘a l loop’ chimaera (etc.). All loop chimaeras were 
cloned into the pZeoSV2+ mammalian expression vector containing a constitutive 
SV40 promoter region and zeocin antibiotic selection.
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a1 (98 aa) LPEWVR
a.2 (143 aa) LPNWVR
cx3 (137 aa) LPTWVK
a4 (259 aa) LPAWVR
a5 (78 aa) LAPWVR
a6 (125 aa) LPKWVK
a7 (140 aa) LPKWTR
a8 (141 aa) LPRVWR
cx9 (122 aa) LPHWAK
a10 (91 aa) LPAWAR
P1 (125 aa) LPFWVR
p2 (125 aa) LAPWVK
P3 (95 aa) LAPWVK
P4 (133 aa) LASWVK
IKYVACI
KYVACI 
IKYVACI
IKFIACI
fMACI 
IKFAACI 
KFAACI
/AC\
IKRLACi 
■ ■ ■  QFVACi 
■■■KYVACI
KFVACI
KYVACI
KFVACI
Figure 3.2 Intracellular (M 3-M 4) loop chimaeras. A series o f  subunit chimaeras was 
constructed containing the intracellular M3-M4 loop domain from all vertebrate nAChR a and 
P subunits (a l-a lO  and P1-P4). All subunit chimaeras contained a common extracellular 
domain (from the nAChR a7 subunit) and common transmembrane domains (from the 5-HT3A 
subunit). Horizontal lines represent the approximate relative length o f  the various intracellular 
loop domains o f  each subunit. The exact number o f  amino acids (aa) within each o f  these 
subunit domains is indicated next to the subunit name. To illustrate more clearly the location 
o f the loop domains examined, the six N- and C-terminal amino acids o f  each domain are 
indicated. Amino acids which were altered by the introduction o f  Notl and B stZ lll  restriction 
enzyme sites are underlined.
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3.3 Characterisation of loop chimaeras by radioligand binding
The series of subunit ‘loop chimaeras’ examined in this study differ from the 
original nAChR/5-HT3AR chimaera (a74™-5HT3A) 0nly in their intracellular M3- 
M4 loop domain and the added restriction sites. As such, all might be expected to 
bind nAChR a7 subunit selective radiolabelled ligands, such as [125I]aBTX and 
[3H]MLA, unless subunit folding or assembly were disrupted by the intracellular 
loop domain. Both the levels of cell-surface receptors and total levels of receptors 
from disrupted cells were investigated by radioligand binding experiments with 
transiently transfected human embryonic kidney (HEK) tsA201 cells.
3.3.1 Radioligand binding to cell-surface and intracellular receptors
Radioligand binding was performed on disrupted cell preparations to determine 
levels of total-membrane binding. Initial radioligand binding studies were 
performed with [125I]aBTX, but results were inconsistent and difficult to interpret 
due to high levels of non-specific binding in disrupted cell preparations (data not 
shown). To reduce problems associated with non-specific binding, studies with 
disrupted cells were performed with tritiated methyllycaconitine ([3H]MLA), 
rather than [125I]aBTX. For all loop chimaeras, specific binding of [3H]MLA was 
detected, indicating that all loop constructs were able to fold into receptors 
capable of forming a ligand binding site (Figure 3.3). Despite evidence for 
specific radioligand binding to all loop chimaeras, significant differences were
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Figure 3.3 [3H]M LA binding to loop chim aeras expressed in tsA201 cells. Human 
embryonic kidney tsA201 cells were transfected with ‘loop chimaeric’ DNA and assayed for 
[3H]MLA binding 42-54 hours post transfection. Total-membrane [3H]MLA binding as 
determined by assaying disrupted cells using a single saturating concentration o f  10 nM  
[3H]MLA. Data are presented as fmol/mg protein and are means o f  n=5 independent 
transfections, with each individual binding assay performed in triplicate. Error bars represent 
SEM.
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observed in the level of binding (Table 3.1). Since there is extensive evidence 
that unassembled subunits do not form a high affinity nicotinic ligand binding 
site, the differences in levels of [3H]MLA binding suggest that the M3-M4 
intracellular loop domain can exert a profound influence on subunit folding and 
assembly.
3.3.2 Radioligand binding to cell-surface receptors
Intact transfected tsA201 cells were examined by cell-surface iodinated a- 
bungarotoxin ([ I]aBTX) binding. Radioligand binding was performed with 
[125I]aBTX (a membrane-impermeant ligand), rather than with [3H]MLA, to 
prevent detection of intracellular receptors. Significant differences were observed 
in the level of specific cell-surface [ I]aBTX binding with different loop 
chimaeras (Figure 3.4; Table 3.1). The highest levels of cell-surface [125I]aBTX 
binding were detected with chimaeras containing the a l, a4, a7 and a 8 loop 
domains (~ 1400-1800 fmol/mg protein). Intermediate levels of cell-surface 
[ ,25I]aBTX binding (~500-750 fmol/mg protein) were detected with chimaeras 
containing the a3, a 6  and 5 -HT3B loop domains (Figure 3.4). In contrast, specific 
cell-surface binding of [125I]aBTX was low or absent with chimaeras containing 
a2, a5, a9, alO, p i, p2, p3 and P4 loop domains (Figure 3.4). Levels of 
[ I]aBTX binding to loop chimaeras are summarised in Table 3.1. For several 
loop chimaeras, differences are apparent between the level of cell-surface binding 
compared with the level of radioligand binding detected in disrupted cells. This is
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Figure 3.4 [125I]aBTX binding to loop chim aeras expressed in tsA201 cells. Human 
embryonic kidney tsA201 cells were transfected with’ ‘loop chimaeric’ DNA and assayed for 
[125I]aBTX binding 42-54 hours post transfection. Cell-surface [125I]aBTX binding as 
determined by assaying intact cells using a single saturating concentration o f  10 nM 
[125I]aBTX. Data are presented as fmol/mg protein and are means o f  n=3-7 independent 
transfections, with each individual binding assay performed in triplicate. Error bars represent 
SEM.
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particularly notable for loop chimaeras such as p2 , for which moderate to high 
levels of radioligand binding was detected in disrupted cells but little or no 
binding was detected on the cell surface. It appears, therefore, that the M3-M4 
loop domain can exert an influence upon the efficiency with which assembled 
receptors are transported to the cell surface.
3.4 Characteristion of loop chimaeras by immunoblotting
In order to detect levels of total subunit protein an ‘epitope tag’ was introduced 
into loop chimaera cDNAs by site-directed mutagenesis (Figure 3.5). An eight 
amino acid (DYKDDDDK) recombinant FLAG epitope tag (Brizzard et al., 
1994), was added to the extreme C-terminal end of the loop chimaeras (Figure 
3.5) to facilitate immunoblotting. This was done primarily to examine whether 
differences in levels of radioligand binding could be attributed to differences in 
levels of subunit expression.
FLAG-tagged subunit chimaeras were expressed in HEK tsA201 cells and 
metabolically radiolabelled (with [35S]methionine and [35S]cysteine). Tagged 
subunits were immunoprecipitated with the commercially available monoclonal 
anti-FLAG antibody (mAb FLAG-M2) and examined by SDS-PAGE, followed 
by autoradiography (Figure 3.6).
106
FLAG-TAG
DYKDDDDK
Loop Chimaera
Figure 3.5 Introduction of a FLAG epitope tag into ‘loop chim aeras’. Schematic 
representation showing the membrane topology o f  a loop chimaera receptor subunit and the 
position o f  the inserted eight amino-acid FLAG epitope tag (DYKDDDDK). The FLAG-tag 
was introduced to the extreme C-terminal end o f  the protein, immediately prior to the stop 
codon.
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The a4, a5 and a6 loop constructs were selected for immunoblotting studies (as 
examples of constructs displaying high, low and intermediate levels of cell- 
surface [125I]aBTX binding, respectively. Bands of the expected molecular 
weight were detected for all three subunit chimaeras and were of a similar 
intensity (Figure 3.6). This would suggest that differences in the levels of cell- 
surface [125I]aBTX binding are not a consequence of differences in the levels of 
expressed subunit protein.
3.5 Characterisation of a potential ER retention signal
All the receptor subunit loop chimaeras investigated in this study share a common 
N-terminal domain of the a7 nAChR subunit and the 4-transmembrane domain 
from the 5-HT3aR subunit. They differ only in the sequence of the M3-M4 
intracellular loop. The sequences of the cytoplasmic loop are the least conserved 
part of the protein molecule between family members and exhibit considerable 
diversity between each other. It is possible that sequences found within this 
region of the protein are determinants of receptor maturation and/or transport to 
the cell surface. Various sequence motifs have been identified within the 
cytoplasmic regions of ion-channels which can regulate intracellular trafficking 
(Moss and Henley, 2002; Michelsen et ah, 2005). A possible explanation for the 
low levels of cell surface receptor, such as those displayed by the chimaeric loop 
constructs a2, a5, a9, alO, pi, p2, p3 and P4, as assayed by [125I]aBTX binding
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Figure 3.6 Immunoprecipitation of FLAG-tagged loop chimaeras. Tagged chimaeras were 
immunoprecipitated from metabolically-labelled human tsA201 cells and examined by SDS- 
PAGE. Immunoprecipitation showing the FLAG-tagged chimaeras containing the loops from 
nAChR subunits a4, a5 and a6, as examples o f  loops that display high, low and intermediate 
[125I]aBTX cell-surface binding, respectively. The figure shown is representative o f  n=3 
independent experiments. The positions o f  the molecular weight markers are shown on the 
left.
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(Figure 3.3), could be the so called ER retention signal (Michelsen et a l,  2005). 
The ER is an important quality control checkpoint within the cell and protein 
subunits must be correctly folded and assembled in order to exit. The masking of 
ER retention motifs by assembly with another subunit, interactions with other 
proteins or phosphorylation may regulate the forward trafficking of such proteins 
(Michelsen et a l , 2005). Indeed, studies of nAChR assembly suggest that exit 
from the ER is an important checkpoint for controlling receptor stoichiometry 
(Blount et al., 1990).
As discussed earlier (Section 3.3), the p2 loop chimaera is notable in forming 
relatively high levels of intracellular radioligand binding but very low levels of 
cell-surface binding sites. Analysis of the M3-M4 loop domain of the (32 subunit 
identified an 18 amino-acid arginine-rich region (Figure 3.7). This sequence 
contains a repetitive string of seven ‘RXR’ motifs (where ‘R’ represents an 
arginine residue and ‘X’ represents any amino-acid). The amino-acid sequence 
‘RXR’ has previously been reported to play a role in the ER retention of a number 
of receptors (Michelsen et a l , 2005), including K a t p  channels (Zerangue et a l , 
1999), G A B A b (Margeta-Mitrovic et a l , 2000), NMDA (Standley et a l , 2000; 
Scott et a l , 2001), 5-HT3B (Boyd et a l, 2003) and Kainate receptors (Nasu- 
Nishimura et a l , 2006). Because the p2 loop chimaera displayed very low levels 
of cell-surface receptor when expressed in HEK cells (Figure 3.3), it was reasoned 
that the deletion of the 18 amino-acid RXR motif containing sequence might lead 
to an increase in the cell-surface levels of the chimaeric receptor.
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Figure 3.7 Deletion o f an RXR-m otif in the 02 loop chimaera and influence on cell- 
surface [125I]aBTX binding. Site-directed mutagenesis was used to delete the 18 amino-acid 
long RXR-m otif (a), present within the intracellular M3-M4 loop sequence o f  the nAChR 02 
subunit, from the 02 Loop chimaera to create 02 LoopARXR chimaera. (b) Cell-surface [125I] 
aBTX binding conducted in tsA201 human embryonic kidney cells to determine the effect o f  
the RXR-motif deletion on the number o f cell-surface 02 Loop receptors. Receptor binding 
was assayed using a single saturating concentration o f  10 nM [ ,25I]aBTX. The a7 Loop 
chimaera, which normally displays high cell-surface binding, was used as a positive control. 
Data are presented as fmol/mg protein and are means o f n=3 independent transfections, with 
each individual binding assay performed in triplicate. Error bars represent SEM.
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The multiple RXR motif-containing sequence was removed from the p2 loop 
chimaera by site-directed mutagenesis to create ‘p2 loopARXR’ and expressed. As 
previously, cell-surface [125I]aBTX binding was performed with transiently 
transfected tsA201 cells. Deletion of the multiple RXR motif-containing 
sequence did not have any significant effect on the levels of cell-surface 
[125I]aBTX binding (Figure 3.7).
3.6 Receptor targeting
The loop chimaeras provide a useful tool by which to examine the influence of 
intracellular domains of individual nAChR subunits on properties such as receptor 
distribution and targeting. All the loop chimaeras contain the same a7 
extracellular N-terminal aBTX binding domain, allowing cell targeting to be 
investigated by fluorescently conjugated aBTX (Alexa-488 aBTX).
3.6.1 Receptor targeting in MDCK cells
Madin-Darby canine kidney (MDCK) cells have been used extensively to 
examine the targeting of transmembrane proteins (Mellman, 1995; Nelson and 
Yeaman, 2001) and have also been used to demonstrate the influence of subunit 
composition upon the targeting of GABAa receptors (Connolly et a l , 1996). 
Cultured MDCK cells establish clearly defined and easily identifiable polarised
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membranes. In addition, there is evidence to indicate that sorting of 
transmembrane proteins to epithelial apical and basolateral membranes is a useful 
model for axonal and dendritic sorting in neurones (de Hoop and Dotti, 1993).
The influence of intracellular loop domains upon receptor targeting was examined 
by expression of loop chimaeras in polarised epithelial MDCK cells. 
Fluorescence confocal microscopy was used to detect the distribution of subunit 
chimaeras labelled with Alexa-488 aBTX (Figure 3.8a and 3.8c). For 
comparison, staining of endogenous E-cadherin, which is expressed exclusively 
on basolateral membranes (Mays et a l,  1995), was examined (Figure 3.8b and 
3.8c). Since the selective targeting of E-cadherin to the basolateral membrane is 
dependent on MDCK polarisation (van Beest et a l, 2006), this also provides a 
means of confirming cells are polarised.
Loop chimaeras which displayed high levels of specific [ I]aBTX binding (a l, 
a4, a l  and a8 loop chimaeras) were expressed in polarised MDCK cells. 
Fluorescence confocal microscopy revealed predominantly apical staining for 
chimaeras containing the a4, a l  and a8 loop domains. In contrast, the a l loop 
chimaera displayed a non-polarised (apical and basolateral) distribution (Figure 
3.8a and 3.8c).
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Figure 3.8 Targeting of loop chimaeras examined in polarised epithelial (MDCK) cells.
Confocal images are shown illustrating a non-polarised distribution o f  the a l loop chimaera 
(left hand panels) and a polarised (apical) distribution of the a4 loop chimaera (right hand 
panels). The main images are single confocal section from 15-17 separate 0.5 pm sections. 
Above and to the left o f  the main images are representative X-Z and Y-Z confocal sections 
from each image in which the apical cell surface is located at the top and to the left, 
respectively, (a) Labelling o f subunit chimaeras with Alexa-488 aBTX. (b) Antibody 
(rhodamine) staining o f  endogenous E-cadherin, which is located on the basolateral membrane 
of MDCK cells, (c) Merged images from a and b in which Alexa-488 aBTX staining is shown 
in green and antibody staining o f endogenous E-cadherin is shown in red. Results are 
representative o f  n=3 independent experiments. Scale bars = 7 pm.
114
3.6.2 Receptor targeting in primary hippocampal neurones
Primary hippocampal neurons have frequently been used to investigate aspects 
such as axonal and dendritic sorting as well as intra- and extra-synaptic sorting. 
However, neurones express aBTX sensitive nAChRs endogenously, complicating 
the use of this toxin to assay targeting and expression without a method to 
discriminate between native receptor subunits and the loop chimaeric subunits. 
The FLAG epitope-tagged loop constructs (See Section 3.5) provide a means to 
discriminate between endogenous aBTX sensitive nAChRs. Preliminary studies 
were performed with cultured rat hippocampal neurones to examine their 
suitability for studies of intracellular trafficking of loop chimaeras.
Rat hippocampal cells were cultured and transfected with loop chimaeras using a 
calcium phosphate based transfection protocol. Neurones were co-transfected 
with FLAG-tagged loop chimaeras and an EGFP encoding plasmid to aid 
identification of positively transfected cells. Hippocampal neurones were 
successfully isolated and cultured (Figure 3.9). In addition, specific staining of 
endogenous nAChRs was detected in untransfected neurones with rhodamine- 
aBTX (Figure 3.9). Experiments aimed at transient expression of loop chimaeras 
were performed and evidence for successful transfection of neurones with EGFP 
was obtained (data not shown). However, attempts to detect loop chimaeras in 
transfected hippocampal neurones were not pursued due to a shortage of time.
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Figure 3.9 Cultured hippocampal neurones transfected with a7 loop chimaera, 
displaying aBTX-sensitive staining. Preliminary experiments showing hippocampal 
neurones, isolated from E l 8 rats and cultured for ~7 days prior to transfection using the 
calcium phosphate method. Neurones were processed for immunostaining 2-3 days post 
transfection. Neurones were transfected with FLAG-tagged a7 loop chimaera (a), or vector 
control (b), and viewed under bright-field optics (left panels). The same neurones were 
imaged under fluorescence optics showing Rh-aBTX staining and viewed here as negatives 
(right panels). Scale bar = 50 pm.
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3.7 Rapsyn-induced clustering of nAChRs
Rapsyn (receptor associated protein at the synapse), also known as 43K, is a 
cytoplasmic protein which aggregates with the muscle-type nAChR and is 
essential for the high-density (-10,000 receptors/pm2) clustering of the receptor at 
the vertebrate neuromuscular junction (Witzemann, 2006). Rapsyn-deficient mice 
fail to form nAChR clusters and show severe neuromuscular dysfunction (Gautam 
et a l , 1995). It has been established that rapsyn mediates the clustering of muscle 
nAChRs via interaction with the M3-M4 intracellular loop domain (Huebsch and 
Maimone, 2003).
In a pilot experiment rapsyn was co-expressed with the a l loop chimaera and 
HEK tsA201 cells studied for evidence of receptor clustering by 
immunofluorecence microscopy (Figure 3.10). In the absence of rapsyn, a l loop 
staining appears diffuse and uniformly spread throughout the cell surface. There 
is evidence for the existence of small receptor clusters, as indicated by the 
presence of punctate staining (arrows in 3.10a). Co-expression with rapsyn 
however, leads to a marked difference in the a l loop staining. The receptor no 
longer appears diffuse and uniformly spread throughout the cell surface but is 
instead heavily concentrated in large aggregates, many times larger than the small 
punctae observed in the absence of rapsyn (arrowheads 3.10b). The a l loop- 
staining pattern co-localises well with that of rapsyn, indicating co-localisation of 
both proteins, which is indicative of a protein-protein interaction.
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Figure 3.10 Rapsyn (43K protein)-induced receptor clustering in tsA201 cells examined 
by immunofluorescence microscopy. Human embryonic kidney tsA201 cells were 
transiently transfected with the a l loop chimaera either alone (a), or together with rapsyn (b). 
Cells were permeabilised and processed for immunofluorescence -4 8  hours post transfection. 
Figures show confocal microscope sections displayed here as a stack projection overlay. Cells 
were labelled with aBTX (green; left panel) and rapsyn (red; middle panel). Both channels 
were merged (right panel), to show co-clustering. Arrows indicate small punctate staining and 
arrowheads indicate large clusters o f protein aggregates. Results are representative o f n=3 
independent experiments. Scale bar = 10 pm.
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3.8 The influence of RIC-3 on loop chimaeras
Recent data suggests that the transmembrane chaperone protein, RIC-3, can 
influence the maturation (folding and assembly) of neuronal nACh and 5 -HT3 
receptors (reviewed by Millar, 2008). RIC-3 was originally identified in a genetic 
screen in the nematode worm Caenorhabditis elegans as the protein encoded by 
the gene, resistance to mhibitors of cholinesterase (ric-3; Nguyen et a l, 1995). 
Interestingly, RIC-3 appears to be specific in its chaperone activity; while 
modulating aspects of nACh and 5 -HT3 receptor maturation, it fails to affect other 
neurotransmitter-gated ion channels, including the closely related Cys-loop 
receptor G A BA a (Miller et a l , 1996; Halevi et a l,  2002; Halevi et a l, 2003; 
Lansdell et a l, 2005). RIC-3 has been demonstrated to facilitate the functional 
expression of the homomeric nAChR a7 subunit in ‘non-permissive’ mammalian 
cell lines such as HEK cells (Lansdell et a l, 2005; Williams et a l, 2005). When 
co-expressed in Xenopus oocytes, RIC-3 enhances the functional expression of the 
a l  nAChRs (Halevi et a l, 2002; Halevi et a l, 2003). RIC-3 has also been shown 
to regulate functional expression of heteromeric nAChRs such as a3p4 and a4p2, 
and the related Cys-loop receptor 5 -HT3A subunit when co-expressed in HEK 
cells (Cheng et a l,  2005; Lansdell et a l, 2005; Cheng et a l, 2007). However, 
unlike with the a l  nAChR, conflicting data has been reported for the regulation of 
heteromeric nAChRs and 5 -HT3A receptors by RIC-3. Whereas in mammalian 
HEK cells RIC-3 leads to an enhancement of functional expression of a3p4 and 
a4p2 nAChRs and of 5-HT3aRs, in oocytes expression is suppressed. It is
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possible that the apparent inconsistencies reported are due to the heterologous 
expression systems employed in each study (Millar, 2008).
Cell-surface [125I]aBTX binding to loop chimaeras was examined in HEK tsA201 
cells co-transfected with human RIC-3 (hRIC-3). In contrast to the dramatic 
facilitation of [125I]aBTX binding to the a7 subunit (Lansdell et a l,  2005), 
preliminary data indicated no increase on the levels of cell-surface binding with 
any of the loop chimaeras (data not shown). On the contrary, those loop 
chimaeras which exhibited high levels of cell-surface binding in the absence of 
hRIC-3 were down-regulated when co-expressed with hRIC-3. Five nAChR 
subunit loop chimaeras which exhibited high levels of [125I]aBTX surface binding 
(a l, a4, a6, a7 and a8; Figure 3.4), in addition to the 5 -HT3A loop chimaera, were 
selected for further analysis to confirm the above observation (Figure 3.11). Co-
1 ^  c
expression with hRIC-3 led to a dramatic decrease in the levels of [ IJaBTX 
cell-surface binding of around 70-90% (Figure 3.11). The differences observed 
between loop chimaeras were not found to be significant when tested by ANOVA, 
suggesting that variation within the M3-M4 loop domain did not contribute to the 
observed reduction in the levels of cell surface receptor mediated by co­
expression with hRIC-3.
Interestingly, RIC-3 has been found to consistently decrease the levels of 
expression of a7/5-HT3A subunit chimaeras in both oocytes and mammalian cell 
expression systems (Millar, 2008). It would appear from these experiments that
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Figure 3.11 Influence of RIC-3 on the cell-surface expression o f M 3-M 4 loop chim aeras 
in tsA201 cells. Human embryonic kidney tsA201 cells were transiently transfected with loop 
chimaeras alone or co-expressed with RIC-3. Cell-surface [125I]aBTX binding as determined 
by assaying intact cells using a single saturating concentration o f  10 nM [125I]aBTX. Results 
are presented as a percentage o f  specific cell-surface binding in the absence o f  RIC-3 (100%). 
In the presence o f  RIC-3, cell-surface [125I]aBTX binding is reduced by -70-90%  between the 
different loop constructs shown. No significant differences were found between the different 
loop constructs examined. Data are means o f  n=3-5 independent transfections, with each 
individual binding assay performed in triplicate. Error bars represent SEM.
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variation between the M3-M4 intracellular loops does not influence the effect of 
hRIC-3 on a7/5-HT3A chimaeric subunits expressed in HEK cells.
3.9 Discussion
The construction of a series of loop chimaeras has revealed the importance of the 
nAChR M3-M4 intracellular domain upon subunit folding and assembly. In 
addition, evidence has been obtained which indicates that this domain is important 
in influencing the cell-surface expression and targeting of nAChRs.
Further work will be required to enable targeting of loop chimaeras to be 
examined in primary hippocampal neurones, but this will be a longer-term goal 
for the laboratory. It is likely that the loop chimaeras will provide a useful tool 
with which to examine the M3-M4 loop domain with intracellular proteins. Initial 
studies have been conducted with rapsyn, a protein associated with muscle-type 
nAChRs, but this is potentially an important area for further research. It would be 
interesting, for example to examine protein-protein interactions by techniques 
such as immunoprecipitation. By use of techniques such as site-directed 
mutagenesis, it is possible that the influence of discrete regions and specific 
sequence motifs within the M3-M4 loop domain may be identified.
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Table 3.1 Characterisation of loop chimaeras
Loop chimaera [l25I]aBTX 
binding 
(fmol mg'1) 
(«=4-7)
[3H]MLA 
binding 
(fmol mg'1) 
(«=5)
Targeting
(MDCK
cells)
a l loop (a7/5-HT3A“'' loop) 1857±346 * 1424±111 c Non-polarised
a2 loop (a7/5-HT3A“2'lo°p) 132±34b 353±39d ND
a3 loop (a7/5-HT3 A“3‘l0°p) 502±158 388±75 d ND
a4 loop (a7/5-HT3A°4'l“°p) 1457*259* 1635±197c Apical
a5 loop (a7/5-HT3Aa5‘l00p) 139±48b 1008±148 c ND
a6 loop (a7/5-HT3Ao6’loop) 718±193 1037±50c ND
a l  loop (a7/5-HT3A“7'lo°p) 1391*307“ 1187±89 c Apical
a8 loop (a7/5-HT3Aa8’loop) 1442*429 “ 1139±189 c Apical
a9 loop (a7/5-HT3Aa9‘loop) 13*5 b 272±41 d ND
alO loop (a7/5-HT3Aal0'loop) 179*69b 592±60 ND
(31 loop (a7/5-HT3A|il-|oop) 129*48 b 381±50d ND
P2 loop (a7/5-HT3Ap2'lo°p) 41*16b 775±24 ND
P3 loop (a7/5-HT3Ap3‘loop) 40*12 b 269±18d ND
p4 loop (a7/5-HT3/ Woop) 5*2 b 88±10d ND
Binding data are ±SEM from experiments conducted in either intact cells or 
disrupted cell membrane preparations using a single saturating concentration of 10 
nM [125I]aBTX or 10 nM [3H]MLA, respectively. Statistical significance: a vs b 
P O .0 5 ,0 vs d P<0.05. ND = not determined.
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Chapter 4
Functional characterisation of nAChR loop chimaeras
4.1 Introduction
The experiments described in the previous chapter provide evidence that the M3- 
M4 intracellular loop domain can influence the ability of nAChR subunits to form 
correctly folded ligand-binding sites expressed on the cell surface (Sections 3.3 
and 3.4). In addition, evidence has been found to support a role of the 
intracellular loop in trafficking of receptors to discrete subcellular domains 
(Section 3.6). However, the studies described in the previous chapter do not 
address the question of whether these subunit chimaeras are able to generate 
functional agonist-gated ion channels. To examine this question, all loop 
chimaeras were initially assayed for function using an intracellular calcium assay 
in transfected mammalian cells. Based on these results, the functional properties 
of various loop chimaeras were investigated further by whole-cell 
electrophysiological recording.
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4.2 Intracellular calcium assay (FLIPR)
Human embryonic kidney (tsA201) cells were transiently transfected with the 
M3-M4 intracellular loop chimaeras. Transiently transfected cells were re-plated 
into 96-well plates and loaded with the fluorescent calcium-sensitive dye Fluo-4 
(Section 2.9). A fluorometric imaging plate reader (FLIPR) was used to measure 
the influx of calcium in response to agonist application (Figure 4.1). A baseline 
was established and, after 25 seconds, agonist was added simultaneously to all 
wells of the 96 well plate.
Previous work has shown that the nAChR agonist 1,1-dimethyl-4-
9 4 *phenylpiperazinium (DMPP) leads to an increased level of intracellular Ca in 
cells transfected with the a74™-5HT3A chimaera, as demonstrated by the use the
9 4 *intracellular Ca -dependent fluorescent dye, Fluo-4, and assayed by FLIPR (Gee 
et al., 2007). A concentration-dependent agonist-induced increase in intracellular 
Ca2+ concentration was also observed with ay4™-5**13^ 017851) (Figure 4.1), the 
chimaera from which the loop chimaeras were constructed (Section 3.2).
Agonist-induced elevations of intracellular calcium were detected in cells 
transfected with some, but not all of the loop chimaeras (Figure 4.2). 
Surprisingly, a number of loop constructs which demonstrated high levels of cell- 
surface [125I]aBTX binding (e.g. a l and a4 loop, Figure3.4), did not exhibit any
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Figure 4.1 A gonist-induced dose-dependent calcium response, as determ ined by FLIPR  
in tsA201 cells transfected with a l  loop chim aeras. (a) The chimaeric a7 loop construct was 
expressed in tsA201 cells and calcium influx, in response to applied DMPP, measured using a 
fluorescence imaging plate reader (FLIPR), as an assay for function o f  the loop construct. 
Black scale bar represents the time and duration o f  agonist application, (b) Concentration- 
response relationship obtained from analysing calcium influx FLIPR responses at various 
concentrations o f  applied DMPP. Scale bars represent SEM o f  triplicate responses obtained 
from a single experiment. Both panels are representative examples o f  the typical responses 
observed over n = 3-5 experiments.
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functional response in the FLIPR assay (data not shown). Moreover, evidence of 
functional expression was detected for subunits that demonstrated little, or very 
low surface binding (e.g. a3 and alO loop, Figure 4.2). These constructs, which 
would perhaps be expected to show little or no function, did exhibit convincing 
and reproducible responses using the FLIPR assay (Figure 4.2). In addition, the 
functional responses did not appear different to those obtained from loop 
chimaeras which demonstrated high surface expression, as determined by surface 
binding (e.g. compare a8 loop versus alO loop; Figure 4.2). The a7 loop 
chimaera was the only construct where the FLIPR response traces were much 
larger than the other functional loop chimaeras; reaching a normalised response 
more than double that of any other loop chimaera which exhibited a FLIPR 
response (Figure 4.2).
In the present study, the FLIPR-based assay has been used primarily as a 
screening tool to identify loop chimaeras which are able to generate functional 
receptors. To an extent, it may be possible to conclude from this data the relative 
efficiency with which the chimaeras generate functional receptors, although no 
information is available about the relative calcium permeability of the different 
loop chimaeras.
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Figure 4.2 A gonist-induced calcium response, as determ ined by FLIPR  in tsA201 cells 
transfected with loop chim aeras. Loop chimaeric constructs were expressed in tsA201 cells 
and calcium influx, in response to 50 pM applied DMPP, measured using a fluorescence 
imaging plate reader (FLIPR), as an assay for function o f  the loop construct, (a) rat a3 loop, 
(b) rat a7 loop, (c) chick a8 loop, (d) rat alO loop, (e) mouse 5-HT3A and (f) human 5-HT3B 
loop. Black scale bar represents the time and duration o f  agonist application. Results are 
representative examples o f  n=3-10 independent experiments conducted in triplicate.
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4.3 Characterisation of loop chimaeras by whole-cell recordings
All six loop-constructs that demonstrated functional responses as determined by 
the FLIPR assay (a3, a7, a8, alO, 5-HT3A and 5-HT3B) were also examined by 
whole-cell patch-clamp recording. The purpose of these experiments was to 
examine in more detail the functional properties in single cells, as opposed to a 
population of cells and to allow rapid agonist application to single cells to provide 
a much higher time resolution of the time course of the response to agonist 
application than is possible using the FLIPR. Receptor properties such as single 
channel conductance and desensitisation were investigated. Human embryonic 
kidney tsA201 cells were co-transfected with the loop chimaeras and a plasmid 
expressing enhanced green fluorescent protein (EGFP). This permitted 
identification of cells successfully transfected, by means of immunofluorescent 
microscopy. An impetus for these studies was recent evidence that the M3-M4 
intracellular loop domain can exert a dramatic influence upon single channel 
conductance of members of the Cys-loop receptor family (Kelley et a l , 2003; 
Hales et a l, 2006; Gee et a l, 2007).
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Figure 4.3 Influence o f nAChR subunit loop domains upon single channel conductance.
Chimaeric subunits containing the M 3-M 4 intracellular loop domain from the a3 subunit (a), 
a8 subunit (b) or alO subunit (c) were expressed in tsA201 cells and analysed by whole-cell 
recording. Representative whole-cell responses were obtained by a 20 second application 
(thick horizontal scale bar) o f  50 mM DMPP. Vertical scale bars = 100 pA. Below each 
whole-cell response is shown a high-gain band-pass filtered (2Hz -  2kHz) record illustrating 
the increase in noise variance associated with each response. Vertical scale bars = 10 pA.
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4.4 Determination of single-channel conductance
In order to determine the single-channel conductance from a whole-cell response, 
the responses of cells to long agonist applications (20 seconds) were measured. 
Figure 4.3 shows representative whole-cell traces (DC and AC coupled) obtained 
from a 20 second application of 50 pM DMPP, for each of the loop chimaera 
constructs examined.
The single-channel conductance can be estimated either by noise power spectral 
density analysis (Figure 4.4) or noise variance analysis (Figure 4.5). When the 
whole-cell responses for each loop chimaera were analysed by noise analysis, 
both types of method gave similar conductance estimates. The final single­
channel conductance estimates given here, are an average of both methods (Figure 
4.6)
As mentioned earlier, previous studies have shown that the M3-M4 intracellular 
loop domain can influence single channel conductance (Kelley et al., 2003; Hales 
et a l, 2006; Gee et a l, 2007). Whole-cell recordings have previously been used 
in this laboratory to examine the influence of receptor domains upon single­
channel conductance, estimated by noise-analysis (Gee et a l, 2007). These 
studies revealed that a7 V201*5HT3A (which contains a 5 -HT3A intracellular loop) 
generated receptors with a single channel conductance of 0.8±0.1 pS, which is not 
significantly different from the sub-pS conductance observed with the 5-HT3A
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Figure 4.4 Estim ation o f single-channel conductance using the noise pow er spectral 
density m ethod. Subunit chimaeras containing the M 3-M 4 intracellular loop domain from the 
a3 subunit (a), a8 subunit (b) or alO subunit (c) were expressed in tsA201 cells. W hole-cell 
recordings obtained by applying 50 jiM DMPP for 20 seconds were analysed to obtain the 
single channel conductance (y).
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Figure 4.5 Estim ation o f single-channel conductance using the noise variance m ethod.
Subunit chimaeras containing the M 3-M 4 intracellular loop domain from the a3 subunit (a), 
a8 subunit (b) or alO subunit (c) were expressed in tsA201 cells. W hole-cell recordings, 
obtained by applying 50 pM DMPP for 20 seconds, were analysed to obtain the single channel 
conductance (y).
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subunit (0.7±0.1 pS), recorded under identical conditions. The subunit chimaera 
containing the a7 intracellular loop (a 74™-5HT3A) was shown previously to 
generate receptors with a single-channel conductance of 30.5±4.0 pS (Gee et al., 
2007), which is significantly larger (PO.OOl) than the sub-pS conductance of the 
ayV20i-5HT3A chimaeraj which differs from a74™-5HT3A only in the loop region
(Gee et a l, 2007).
Using identical experimental conditions, noise analysis of whole-cell responses 
was performed to determine the single channel conductance of the loop chimaeras 
in this study, containing the a3, a7, a8, alO, 5-HT3A and 5 -HT3B loop domains. 
The a7 loop and the 5 -HT3A loop chimaeras are essentially equivalent to the 
previously described a74™-5HT3A and a7v201'5HT3A chimaeras, respectively (Gee et 
al., 2007). For this reason they would be expected to form receptors with a 
similar channel conductance. Both chimaeras (in common with all of the loop 
chimaeras constructed in this study), do however, contain two amino acid 
differences from the previously described a 74™-5HT3A chimaera; a methionine to 
leucine and valine to isoleucine change, which arose due to introduction of the 
Notl and B stZ lll  sites into a 74™-5HT3A (see Figure 3.1). Thus, it was decided to 
determine the single channel conductance of all the new loop chimaeras described 
in this study (including the a l  loop and 5-HT3A loop chimaeras).
The single channel conductances determined in this study for the a l  loop 
chimaera (36.1±3.2 pS, w=8) and the 5 -HT3A loop chimaera (0.48±0.04 pS, n=5),
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were not significantly different to those determined previously for the a 7 4™'5HT3A 
(30.5±4.0 pS) and the a 7 V201'5HT3A (0.8±0.1 pS) chimaeras (Gee et a l,  2007). 
Reassuringly, these and other data, help support the conclusion that introduction 
of the Notl and B stZ lll restriction sites do not significantly alter the properties of 
the chimaeric receptor.
Of the nAChR loop chimaeras examined (a3, a l, a8, a 10, 5 -HT3A and 5 -HT3B; 
Figure 4.6), four loop chimaeras generated receptors with high single-channel 
conductances; a3 loop (29.4±2.8 pS, n=9), a l  loop (36.1±3.2 pS, n= 8), a8 loop 
(24.9±0.8 pS, n=5), and 5-HT3B loop (34.0±6.6 pS, n=5). These single-channel 
conductances were not significantly different from one another (Table 4.1), as 
determined by analysis of variance (ANOVA, with Tukey’s post test). The 
receptor exhibiting the lowest single-channel conductance was that containing the 
5 -HT3A loop (0.48±0.04 pS, n= 5). This was significantly lower than all other loop 
chimaeras investigated (PO.OOl). The alO loop chimaera displayed an 
intermediate single-channel conductance (10.5±1.7, n=5), which was both 
significantly smaller (PO.OOl) than that observed with the high conductance 
chimaeras (a3, a l, a8 and 5 -HT3B loop); and significantly larger (B<0.001) than 
that observed with the 5 -HT3A loop chimaera.
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Figure 4.6 Single-channel conductance o f  loop chim aeras. The single-channel conductance 
values were obtained as an average from both the power specral desity method and the noise 
variance method for analysing whole-cell noise traces. The data are presented here in the 
form o f  a boxplot (a), and as a scatterplot o f  observations (b). The mean conductance values 
(± SEM; n = 5-9) for each construct are presented above each respective column.
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4.5 Desensitisation properties
The influence of the intracellular loop upon desensitisation was also examined. 
All loop chimaeras tested showed extensive desensitisation (~90%), the extent of 
which did not differ significantly between the constructs (Figure 4.7 and 4.8). 
However, significant differences were detected in the time constant for 
desensitisation for different loop chimaeras (Figure 4.7 and 4.9). The 
desensitisation time constants for chimaeras containing the a7 (1334±141 ms, 
n=21), a8 (966±184 ms, n=6), and 5 -HT3B loop domains (1200±70 ms, n=3), 
were significantly larger (Z^O.OOl) than those determined with chimaeras 
containing the a3 (278±23 ms, nl2) and alO loop domains (217±16 ms, n=8). 
Unfortunately, desensitisation properties could not be investigated in detail for the 
responses obtained from the 5 -HT3A loop chimaera, as only two responses were 
suitable for analysis. However, the preliminary desensitisation time constant 
obtained for the 5 -HT3A loop (111.6±38 ms, n=2), is in good agreement with 
previously published results for a7 v201-5HT3A (223±32) (Gee et a l,  2007) and 
indicate a desensitisation time constant for the 5 -HT3A loop, similar to those 
obtained for the a3 and alO loops.
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Figure 4.7 Influence o f nAChR intracellular domain upon the kinetics o f  desensitisation.
The a7 loop (a) and alO loop (b) are shown as examples o f  chimaeras with slow  and fast 
desensitisation, respectively. Subunit chimaeras were expressed in tsA201 cells and w hole-cell 
responses obtained by 20 second applications o f  50 pM DMPP. These were inverted and fitted 
with one or the sum o f  two exponential functions o f  the form I = Iss+Imax*^'1^ ,  where Iss =  
steady state current, Imax = peak steady state current, x = time constant. The inserts show, on an 
expanded timescale, the fit to the initial part o f  the response. Traces are representative 
examples o f  n = 8-21 responses from 3-12 cells.
139
88.9 ±6.1 95.2 ± 0.8 95.0 ±0.8 86.6 ±4.9
100 i
CDW
I  75-
CO
£ 5
c  8 . 50 -
CO —  
CD CD
Q CO
to
"cO
CD
25 -
CO
a3  Loop a7  Loop a8  Loop alO L oop
Figure 4.8 Percentage desensitisation o f whole-cell responses from tsA201 cells 
transiently transfected with loop chimaeras. The mean percentage desensitisation o f  whole­
cell responses obtained by applying 50 pM DMPP for 20 seconds. The responses were 
inverted and fitted as described in the legend for Figure 4.7. From this, the steady state current 
/  peak response current was determined. The values o f  each response obtained per cell were 
averaged and presented as n= 3-8 cells.
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Figure 4.9 Desensitisation time constant analysis o f whole-cell responses from tsA201 
cells transiently transfected with loop chimaeras. The mean time constant o f  desensitisation 
o f  whole-cell responses obtained by applying 50 pM DMPP for 20 seconds. The responses 
were inverted and fitted as described in the legend for Figure 4.7 and the time constant 
determined. The values o f  each response obtained per cell were averaged and presented as n= 
3-8 cells. Error bars are SEM. The differences between groups were tested for significance 
using ANOVA with Tukey’s multiple comparison post-test. *** indicates PO.OOl.
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4.6 Discussion
These results provide evidence that the M3-M4 intracellular loop domain 
influences the functional properties of receptors, such as single-channel 
conductance and the rate of receptor desensitisation. Measuring agonist-induced 
changes in intracellular calcium using a FLIPR-based assay, provides a 
convenient method by which to assess whether the loop chimaeras are able to 
generate functional receptors (Gee et al., 2007). As expected, no evidence of 
functional expression was detected for loop chimaeras which failed to give cell- 
surface [125I]aBTX binding.
Clear evidence of functional expression was observed for the a3, a7, a8, alO 
nAChR loop chimaeras and the 5-HT3R 3A and 3B loop chimaeras. Interestingly, 
there was not a good correlation between those chimaeras which displayed high 
levels of cell-surface [125I]aBTX binding and the size of the response for those for 
which clear evidence of functional expression could be detected. The a l and a4 
loop chimaeras, for example, give high levels of cell-surface [125I]aBTX binding 
but no evidence of functional expression. The a3 and alO loop chimaeras gave 
relatively low levels of cell-surface [125I]aBTX binding, but clear evidence of 
functional expression. It appears, therefore, that the nAChR intracellular loop 
domain can also exert a profound influence upon the ability of subunits, once 
assembled, to generate functional receptors. Similar discrepancies between levels 
of radioligand binding and function have been reported in studies with other types
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of nAChR subunit chimaeras and with subunits altered by site-directed 
mutagenesis (Garcia-Guzman et a l, 1994; Valor et a l,  2002; Castelan et al., 
2007; Gee et a l, 2007).
Despite the well established evidence that the conductance of Cys-loop type 
ligand-gated ion channels is influenced by amino acids located within the second 
transmembrane domain (Imoto et a l, 1988), there is now strong evidence to 
indicate that channel conductance is also influenced by other subunit domains, 
including the M3-M4 intracellular loop (Kelley et a l,  2003; Hales et a l, 2006; 
Gee et a l,  2007). The noise analysis of the loop chimaera responses, presented in 
this study, is entirely consistent with previous data implicating the intracellular 
loop in modulating channel conductance (Kelley et a l, 2003; Hales et a l, 2006; 
Gee et a l , 2007). It has been proposed that the influence of the intracellular loop 
domain is a consequence of positively charged amino acids found in the MA 
region of the subunit intracellular loop (Kelley et a l,  2003; Hales et a l, 2006). It 
has been demonstrated that the replacement of three arginine residues within the 
MA region of the 5 -HT3A subunit with the equivalent residues found in the 5- 
HT3B subunit, results in a dramatic increase in single channel conductance (Kelley 
et a l,  2003). This increase has been confirmed in this study with the 5 -HT3A 
subunit loop displaying a sub-pS single-channel conductance (0.5 pS), and the 5- 
HT3B subunit loop displaying a conductance considerably higher (34 pS). In 
addition, differences in single-channel conductance have been described here
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showing that the loop domain of nAChRs can also dramatically influence single­
channel conductance.
Inspection of the MA region of the subunit loops examined in this study (<x3, a7, 
a8, alO from nAChRs and 3A and 3B from the the 5-HT3Rs) indicates that these 
findings are in general agreement with the proposal that positively charged amino 
acids in this region are important (Figure 4.10). It is possible, however, that 
charged amino acids other than the three arginines mutated by Kelley et al. are 
able to exert an additional influence on single channel conductance of the loop 
chimaeras. There appears to be a trend, whereby loop chimaeras containing more 
positively charged residues and/or fewer negatively charged residues within the 
MA region of the M3-M4 loop display lower single-channel conductance (Figure 
4.10). The number of positively charged residues is greater and the overall net 
charge is more positive in the MA region of the nAChR loop chimaera with the 
lowest conductance (a 10) than in those with the highest conductance (a3, a7 and 
a8), although there appears to be no direct relationship between net charge and 
conductance as is observed for the M2 domain rings of negative charge of the 
muscle nAChR (Imoto et al., 1988). The difference in conductance between the 
5-HT3a loop (0.48 pS) and the 5-HT3b loop (34 pS) observed here, is in agreement 
with previous studies where the MA-helix region in the human 5-HT3aR (0.76 pS) 
was replaced with the same region from the 5-HT3bR (22.24 pS) and expressed in 
HEK tsA201 cells (Kelley et al., 2003).
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Figure 4.10 Amino acid sequence alignm ent o f  the M A region o f nAChR and 5-HT3R  
subunits. Sequences are shown for all loop chimaeras for which single channel conductance 
was determined by noise analysis. Amino acids with positively and negatively charged side 
chains are indicated (by + and -, respectively). The total number o f  positively charged 
residues, negatively charged amino acids and the overall net charge within the MA region is 
indicated (within parentheses, on the right hand side). The species o f  each subunit used for 
construction o f  the loop chimaeras is shown next to the subunit name (c, chick; h, human; m, 
mouse; r, rat).
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A possible explanation for the differences in conductance observed is that when 
the MA-helix region is more positively charged (e.g. 5-HT3aR and nAChR alO), 
the intracellular loop domain is providing the region of the protein that is rate- 
limiting for ion permeation, or is allosterically influencing the conduction path of 
the channel. In contrast, when the MA-helix region is more negatively charged 
(e.g. 5-HT3BR, nAChR a3, a7 and a8), the subunit loop is not rate-limiting for ion 
permeation and so some other region of the protein then determines the overall 
single channel conductance. The high-resolution structure of the nAChR lends 
support to this hypothesis (Unwin, 2005). The MA-helix region is thought to 
contribute to the “vestibule-like” structure protruding from the membrane bilayer 
into to the cytoplasm of the cell. It has been postulated that this portion of the 
receptor acts as a further filter to ions passing though the ion-channel pore (Peters 
et a l , 2005; Unwin, 2005).
It has also been found that the M3-M4 intracellular domain influences the rate of 
receptor desensitisation (Figure 4.9). This is perhaps a surprising finding, given 
that residues within the M2 transmembrane domain of nAChRs were previously 
shown to be major determinants of the rates of receptor desensitisation (Revah et 
al., 1991). There is, however, evidence that subunit domains other than M2 can 
influence desensitisation. Recent studies with nAChR/5-HT3R subunit chimaeras 
have demonstrated that the N-terminal extracellular domain can influence receptor 
desensitisation (Gee et al., 2007), as might be expected given that receptor 
desensitisation is coupled to receptor activation, and that the N-terminal domain
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must be where receptor activation is initiated. Taken together, these results 
indicate that receptor desensitisation can be influenced by a variety of subunit 
domains.
Given the predicted conservation of structural elements throughout the Cys-loop 
family of receptors, it is likely that the intracellular loop will influence functional 
properties, such as conductance and desensitisation, not only of the nAChR and 5- 
HT3R members but of glycine and GABA receptors too.
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Table 4.1 Functional characterisation of loop chimaeras
Loop chimaera Functional
expression*
Conductance
(pS)
02=5-9)
Time constant 
for
desensitisation
(ms)
(«=6-21)
al loop (a7/5-HT3Aal''oop) No ND ND
a2 loop (a7/5-HT3A“2-|°op) No ND ND
a3 loop (a7/5-HT3Aa3‘l00p) Yes 29.4±2.8 a 278±23d
a4 loop (a7/5-HT 3 Aa4"loop) No ND ND
a5 loop (a7/5-HT3A<l5'loop) No ND ND
a6 loop (a7/5-HT3A°Woop) No ND ND
a l  loop (a7/5-HT3Aa7‘loop) Yes 36.1±3.2 a 1334±141 e
a8 loop (a7/5-HT3Aa8'loop) Yes 24.9±0.8 a 967±184e
a9 loop (a7/5-HT3Aa9"'0Dp) No ND ND
alO loop (a7/5-HT3Aal0"loop) Yes 10.5±1.7b 218±16d
pi loop (a7/5-HT3Api'l00p) No ND ND
P2 loop (a7/5-HT3Ap2''0°p) No ND ND
P3 loop (a7/5-HT3A|i3'lo°p) No ND ND
p4 loop (a7/5-HT3Ap4'loop) No ND ND
5 -HT3A loop
(a7/5-HT3A5HT3A'loop) Yes 0.48±0.04 c ND
5 -HT3B loop
(a7/5 -HT3A5HT3B-|oop) Yes 34.0±6.6 a ND
* Functional expression determined by FLIPR-based intracellular calcium assay 
Data are ±SEM
Statistical significance:a vs bc; b v sc PO .O O l,d vs e PO.OOl 
ND = not determined
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Chapter 5
Characterisation of a9a!0 nAChRs
5.1 Introduction
In collaboration with Dr Belen Elgoyhen’s laboratory (Buenos Aires, Argentina), 
two studies were undertaken which made use of existing nAChR/5-HT3A 
chimaeric subunits, to determine the effect of a series of compounds on a9al0  
nAChRs. The first study concerned the effects of three quinoline derivatives 
quinine, quinidine and chloroquine; (Ballestero et a l, 2005), while the second 
study focused on the NMDA receptor antagonists, neramexane and memantine 
(Plazas et a l , 2007).
5.2 a9a l0  nAChRs
The a9 and alO subunits are the most recently cloned vertebrate nAChR subunits 
(Elgoyhen et a l, 1994; Elgoyhen et a l, 2001). As discussed previously (Chapter 
1), the a9 and alO nAChR subunits are unusual, in that they exhibit a very 
specialised expression profile and thus do not fall conveniently into the
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conventional classification of either ‘muscle-type’ or ‘neuronal-type’ nAChRs. 
The a9 and alO subunits are expressed primarily in cochlear and vestibular hair 
cells. Recombinant receptors assembled from a9 and alO subunits exhibit 
functional and pharmacological properties that are similar to native hair cell 
cholinergic receptors. Recombinant a9al0 nAChR expressed in Xenopus oocytes 
show sensitivity to aBTX and a high conductance for Ca2+ (Elgoyhen et a l, 
2001). These similarities to the native receptor strongly suggest that heteromeric 
a9al0  nAChRs mediate cholinergic dependent auditory nerve responses. While 
a9 subunits can form functional nAChRs when expressed in oocytes, alO subunits 
on their own cannot. Indeed, alO coexpressed in pairwise combinations with any 
other nAChR subunit capable of forming heteromeric receptors (a2-a6 or P2-p4) 
failed to elicit any functional responses. Only when coexpressed with a9 are 
functional receptors detected whose biophysical and pharmacological properties 
are similar to those detected from native hair cell nAChRs (Elgoyhen et al., 2001; 
Gomez-Casati et a l , 2005). In situ hybridisation studies have shown that mRNA 
transcripts for both a9 and alO nAChR subunits are present in the outer hair cells 
(OHCs) of the developing and adult cochlea, while in inner hair cells (IHCs) both 
subunit types are coexpressed from late embryogenesis until approximately the 
second postnatal week, when alO gene expression undergoes a developmental 
switch and disappears (Katz et a l , 2004). While a9 mRNA continues to be 
expressed, both mRNA and protein levels of alO are down-regulated to 
undetectable levels which correlates with the corresponding loss of functional 
responses to acetylcholine in these cells (Katz et a l,  2004). These data, along
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with studies conducted in a9 knockout mice showing that the a9 nAChR subunit 
is required for the physiological responses mediated by OHCs (Vetter et al., 
1999), strongly suggest that a9 and alO nAChR subunits form heteromeric 
receptors. Recently, the stoichiometry of the recombinant a9al0  nAChR has 
been elucidated in Xenopus oocytes, using a subunit-specific reporter mutation 
approach (Plazas et a l , 2005). From these studies, it has been concluded that the 
a9al0  nAChR has a pentameric structure of (a9)2(al0)3 (Plazas et al., 2005).
In addition to their expression in the inner ear, a9al0  nAChRs have been found to 
be expressed in dorsal root ganglion (DRG) neurones, where they may play a role 
in pain processing (Lips et a l, 2002). They have also been identified in a variety 
of other tissues, where their role is less well defined, such as lymphocytes, sperm, 
and keratinocytes, and have been implicated in mediating process such as 
neuropathic pain and aspects of the immune response (Vincler et a l, 2006).
5.3 Expression of a9al0  nAChRs in HEK cells
As with the homomeric a7 nAChR, considerable problems have been reported 
with the expression of a9al0 receptors in mammalian expression systems (Millar, 
1999). While a9 and alO nAChRs can generate functional heteromeric receptors 
when reconstituted in frog oocytes (Elgoyhen et a l, 2001), and functional 
homomers in the case of a9 alone (Elgoyhen et a l, 1994), expression in common
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mammalian cell lines has so far proved unsuccessful. Although much can be 
achieved by characterisation of oocyte-expressed nAChRs, some approaches to 
the pharmacological characterisation of a9al0 nAChRs (e.g. equilibrium binding 
studies) have been hindered by the lack of a suitable cultured cell-based 
expression system (Baker et a l, 2004). Previous studies have failed to detect 
functional nAChRs in mammalian cells transfected with nAChRs a9 and alO 
subunits (Lustig et al., 2001). When recombinant a9 and alO nAChR subunit 
DNAs were introduced by transient transfection into cultured mammalian HEK 
tsA201 cells, either alone or in a pairwise combination, no evidence for specific 
high affinity [3H]MLA binding was found (Baker et a l, 2004).
In a previous study in this laboratory, an influenza haemagglutinin (HA) epitope 
tag was added to the a9 and alO subunits (Baker et a l,  2004). Immunoblotting 
studies with HA-tagged a9 and alO subunits identified protein bands of a similar 
size to those expected for full-length a9 and alO subunits (Baker et a l, 2004). 
These data suggest that the absence of specific nicotinic radioligand binding is a 
consequence of inappropriate subunit folding and/or assembly, rather than due to 
problems of inefficient protein synthesis.
Similar problems with receptor expression in transfected mammalian cell lines 
have been encountered with the homomeric a7 nAChR subunit and have been 
attributed to inappropriate folding and/or assembly (Cooper and Millar, 1997). 
Coexpression of the a l  subunit with the nAChR interacting chaperone protein
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RIC-3 alleviates this problem and facilitates efficient expression of a7 nAChRs at 
the cell surface (Lansdell et a l, 2005; Williams et a l, 2005). RIC-3 has also been 
found to up-regulate cell-surface expression of other nAChR subtypes in 
mammalian cell lines, such as a3p4 and a4p2 (Lansdell et a l, 2005). However, 
coexpression of RIC-3 with a9 and alO nAChR subunits, either alone or together, 
fails to produce any functionally and pharmacologically detectable cell surface 
nAChRs in mammalian cell lines such as HEK tsA201 (Lansdell et a l, 2005).
5.4 The interaction of wild-type a9a!0 nAChRs with RIC-3
To investigate the influence of RIC-3 upon a9al0 nAChRs further, HEK tsA201 
cells were transiently cotransfected with a9al0 nAChR subunit cDNAs and 
epitope tagged RIC-3 cDNA. Metabolic radio-labelling and co- 
immunoprecipitaton (Section 2.7) were employed to determine whether or not the 
a9al0  nAChR and RIC-3 show protein-protein association (Figure 5.1). As a 
control, the FLAG-tagged RIC-3 was also co-expressed with the rat P2 nAChR 
subunit, which has previously been shown to associate with RIC-3 in this type of 
assay (Lansdell et a l, 2005). Evidence was obtained for an interaction between 
the FLAG-tagged RIC-3 and P2 nAChR subunit, as expected (Figure 5.1). In 
contrast, little or no co-association was observed with the a9 subunit and much
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Figure 5.1 Co-immunoprecipitation of wild-type rat nAChR subunits with FLAG epitope 
tagged hRIC-3 (hRIC^1^ 0). Human embryonic kidney tsA201 cells were transiently 
transfected with the nAChR subunits (32, a9, alO or a9 and alO together, with hRIC-3FLAG (+), 
or empty vector (-). The cells were then metabolically radiolabeled and cell lysates incubated 
with the monoclonal M2 anti-FLAG antibody. The samples were resolved by SDS-PAGE and 
the relative levels o f proteins detected by autoradiography. Results are from a single 
experiment.
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reduced levels with the alO subunit, when expressed individually. When 
coexpressed the amount of nAChR subunit protein immunoprecipitated was much 
lower than observed with the (32 nAChR subunit control lane but comparable to 
the alO subunit alone (Figure 5.1). It is possible that this evidence for a weaker 
interaction between RIC-3 and the a9 or alO subunits may explain why RIC-3 
fails to facilitate maturation of these nAChRs subunits.
5.5 Characterisation of a9/5-HT3A and alO/5-HT3AR chimaeras
In an effort to overcome problems associated with heterologous expression of 
a9/al0 nAChRs in mammalian cells, a chimaeric receptor approach has been used 
' primarily to investigate various pharmacological and molecular characteristics of 
the a9 and alO receptors (Baker et a l, 2004). Chimaeras were created (a9(L209)/5- 
HT3A; a9x and alO(L206V5-HT3A; alOx), in which the extracellular N-terminal 
domain of the a9 or alO subunits were fused to the transmembrane and 
intracellular domains of the 5-hydroxytryptamine-3A (5-HT3A) subunit (Baker et 
al., 2004). These chimaeras successfully form functional receptors when 
reconstituted in oocytes (Baker et al., 2004). This approach has successfully 
permitted the pharmacological characterisation of recombinant a9/al0  nAChR in 
cultured cell lines. Radioligand binding experiments give a good specific to non­
specific signal, and the chimaeric receptors retain the same pharmacological
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profile when compared to wild-type receptors expressed in Xenopus oocytes 
(Baker et a l, 2004). As described previously, [3H]methyllycaconitine binds with 
high affinity (K& = 7.5 ± 1.2 nM) to cells coexpressing the a9 and alO subunit 
chimaeras (Baker et al., 2004).
5.6 Effects of quinine, quinidine, and chloroquine on a9al0  
nAChRs
In this study, the effects of three quinoline derivatives (quinine, quinidine and 
chloroquine) on a9al0  nAChRs was investigated (Ballestero et a l, 2005).
5.6.1 Introduction
For centuries, the alkaloid quinine, obtained from the bark of the Cinchona tree 
has been the traditional cure against malaria which is caused by members of the 
Plasmodium family of protozoans. In more recent times, synthetically produced 
compounds (e.g. quinoline derivatives) have replaced naturally occurring quinine. 
Data has been obtained to show that the anti-malarial quinoline derivatives 
quinine, quinidine and chloroquine (Figure 5.2) act as antagonists of a9al0  
nAChRs (Ballestero et al., 2005). Side effects of these compounds include 
reversible (but sometimes permanent) sensorineural hearing loss, tinnitus and 
vertigo (Jung et al., 1993). Evidence suggests these compounds mediate their
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Quinine Quinidine
Chloroquine
Figure 5.2 Chem ical structures o f quinine, quinidine, and chloroquine. All the
structures share a common aromatic quinoline moiety (C9H7N) with a methoxy 
substituent. Quinine and quinidine are optical isomers and contain a quinuclidine ring.
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effects via a9al0  nAChRs, further supporting a role for these receptors in 
mediating auditory responses and/or possible auditory protection mechanisms (see 
above).
Functional data from experiments on recombinant a9al0 nAChRs reconstituted in 
Xenopus oocytes, show that quinine, quinidine and chloroquine all block 
acetylcholine evoked responses at micromolar concentrations in a concentration 
dependent manner. Inhibition curves in oocytes have been used to determine the 
rank order of potency: chloroquine, ICsq = 0.39 ± 0.08 pM > quinine, /C50 = 0.97 
± 0.07 pM > quinidine /C50 = 1.28 ± 0.05 pM (Ballestero et al., 2005). Further 
data indicated that the mechanism of block was competitive in nature, as 
determined by concentration-response curves in the presence or absence of 
differing antagonist drug concentrations. The block was fully competitive for 
chloroquine, and at least partially competitive, at lower concentrations, for 
quinine and quinidine. At higher concentrations, it appeared the mode of action 
was also non-competitive for quinine and quinidine (Ballestero et a l , 2005).
To further analyse the nature of the competitive antagonism observed in Xenopus 
oocytes, equilibrium competition radioligand binding studies were performed to 
examine whether chloroquine, quinine and quinidine were able to displace 
binding of the high-affinity nicotinic antagonist, [3H]MLA. Experiments were 
performed to address the nature of the competitive antagonism by carrying out
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displacement binding assays in the mammalian HEK cell line tsA201, transiently 
transfected with a9x and a 10/ receptor.
5.6.2 Competition radioligand binding
As described previously, [ H]MLA binds with high nanomolar affinity (Kd = 1.5 ±
1.2 nM) to cells coexpressing the a9 and alO subunit chimaeras (Baker et al., 
2004). Equilibrium competition binding studies were performed with 
chloroquine, quinine and quinidine to determine their affinity for the a9al0 
receptor (Figure 5.3). In all cases (chloroquine, quinine and quinidine), complete 
displacement of bound [3H]MLA was observed, providing evidence of 
competitive binding to a single high-affinity site. Binding affinities (K\ values) 
and the rank order of potency determined from three independent experiments 
were as follows: chloroquine, 2.3 ± 0.5 pM > quinine, 5.5 ± 0.7 pM > quinidine, 
13.0 ± 2.9 pM. Thus, the rank order of potency was in agreement with that 
obtained from functional data in Xenopus oocytes.
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Figure 5.3 Com petition radioligand binding to transfected m am m alian cells. Cultured 
mammalian tsA201 cells were cotransfected with subunit chimaeras a9(L209)/5-HT3A and 
a jg(L206)/5_jTp3A which the extracellular N-terminal domain o f  the a9 or alO subunits are 
fused to the transmembrane and intracellular domain o f  the mouse 5-HT3A subunit). 
Competition-binding data with chloroquine, quinine, and quinidine is presented as a percentage 
o f  [3H]MLA binding obtained in the absence o f  competing ligand. The curves are from a single 
experiment but are typical o f  three independent experiments.
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5.6.3 Discussion
As described previously, chimaeric a9xal0x receptors were successfully 
transiently transfected into the mammalian tsA201 cell line (Baker et a l, 2004). 
Radioligand displacement binding assays with [3H]MLA were carried out to 
verify the competitive nature of the block established through functional 
experiments, and to determine the K\ of chloroquine, quinine and quinidine on 
a9al0  receptors. As shown (Figure 5.3), all three compounds were able to fully 
displace the bound [3H]MLA with low micromolar affinities, confirming a 
competitive nature to their blocking action. Combined with the data from 
functional studies, in the case of chloroquine, it appears that the blocking action 
on acetylcholine responses is entirely mediated by a competitive mechanism. In 
a9al0  nAChR expressing oocytes, increasing concentrations of chloroquine 
shifted the acetylcholine concentration-response curve to the right, with no 
reduction in the maximal evoked acetylcholine response (behaviour typical of a 
competitive antagonist). In the case of quinine and quinidine, their block appears 
to be mediated by a mixed competitive and non-competitive mechanism. Whilst 
at low concentration of agonist, a rightward shift of the acetylcholine 
concentration-response curve with no reduction in the maximal evoked 
acetylcholine response does occur; at higher concentrations, a rightward shift of 
the concentration-response curve with additional concomitant insurmountable 
antagonism resulted (behaviour typical of a non-competitive antagonist).
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It is noteworthy that the IC50 values calculated from the functional data in the 
presence of acetylcholine (chloroquine, 0.39 pM; quinine, 0.97 pM and quinidine, 
1.37 pM) are lower than the calculated Kx affinities (2.3 pM; 5.5 pM and 13.0 
pM, respectively; Figure 5.3). These results, at first appear to support a 
mechanism other than purely competitive antagonism. Thus, this observation is at 
odds with the hypothesis that chloroquine acts solely as a competitive antagonist 
on a9al0  nAChRs, as described above, since it might be expected that the IC50 
value to be higher than the Kx for a purely competitive antagonist. An alternative 
explanation, which would account for this difference, is that the functional data 
was obtained in a frog oocyte expression system using a9al0  nAChRs; whereas 
the K\ values were calculated from experiments conducted in a mammalian 
expression system (tsA201 cells), using chimaeric a9xal0x receptors. 
Reassuringly, both sets of values are in the same low micromolar range.
5.7 Inhibition of the a9al0 nAChR by neramexane
In a second related study, the effects on a9al0 nAChRs of neramexane, a novel 
amino-alkyl-cyclohexane derivative that is a non-competitive N-methyl-D- 
aspartate (NMDA) receptor antagonist, were investigated (Plazas et a l , 2007).
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5.7.1 Introduction
Neramexane (MRZ 2/579, l-amino-l,3,3,5,5-pentamethyl-cyclohexane), a new 
NMDA receptor antagonist developed by Merz and Co. (Danysz et al., 2002), is 
currently in phase II of clinical trails for various conditions including 
Alzheimer’s disease and chronic pain. Neramexane was developed as a 
therapeutic agent due to its similarities to the previously discovered channel 
blocker, memantine (3,5-dimethyl-1-adamantane; Figure 5.4). Memantine is an 
adamantine derivative, and a well established blocker of ligand-gated ion channels 
permeable to Ca2+ such as the NMDA type glutamate receptor (Chen et al., 1992; 
Parsons et al., 1993; Bresink et al., 1996) or nicotinic acetylcholine receptors 
including a9al0  (Buisson and Bertrand, 1998; Oliver et al., 2001).
Memantine has successfully been used in the treatment of dementia and spasticity 
for over a decade and further clinical and pre-clinical studies indicate a far greater 
therapeutic potential for the drug (Parsons et al., 1999b). Indeed, the potential 
therapeutic application of agents interacting with the glutamatergic system in the 
CNS is enormous and ranges from neuroprotection through pain to psychiatric 
diseases such as schizophrenia and depression (Parsons et al., 1998; Oliver et al., 
2001). Typically, it has been problematic to develop NMDA receptor antagonists 
with a satisfactory side effect to benefit ratio, so memantine has been used as a 
model agent to screen for novel drugs. Neramexane was selected for further study 
as an NMDA antagonist based on its similarity to memantine, with respect to
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Memantine Neramexane
Figure 5.4 Chem ical structures o f neram exane and m em antine. Memantine (l-am ino-3,5- 
Dimytheyl-adamantane), is an adamantane derivative and is characterised by its carbon cage 
structure. Neramexane (l-amino-l,3,3,5,5-pentamethyI-cyclohexane), is an amino-alkyl- 
cyclohexane derivative and is characterised by its 6-carbon ring structure.
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channel blocking kinetics, voltage dependency and affinity (Danysz et a l , 2002).
Data from Xenopus oocytes and in vivo recordings from hair cells have 
demonstrated that, as reported for memantine (Oliver et al., 2001), clinically 
relevant concentrations of neramexane block recombinant a9al0 nicotinic 
acetylcholine receptors in a voltage-independent, non-competitive manner. These 
data therefore support a possible role for neramexane in vivo, in potentially 
unexplored therapeutic areas, via blockade of a9al0-containing nAChRs of 
cochlear hair cells.
5.7.2 Competition radioligand binding
Competition radioligand binding experiments were carried out to determine the 
presence or lack of an interaction between neramexane and the ligand binding 
domain of the receptor, in HEK tsA201 cells transfected with the a9/5-HT3A 
(a9(L209)/5-HT3A; a9yj, and the al0/5-HT3A (alO(L206)/5-HT3A; alOx) receptor 
chimaeras. Complete displacement of bound [ H]MLA was observed for both 
neramexane and memantine (Figure 5.5), but only at very high concentrations of 
competing ligand (Kx = 2.7 ± 0.5 mM; n=5, for neramexane and K\ -  0.8 ± 0.2 
mM; n=3, for memantine). In comparison to the IC50 values for the antagonist 
activity of neramexane and memantine derived from oocyte experiments (0.30 ± 
0.03 pM and 1.2 ± 0.4 pM, respectively), the Kx values determined from 
competition
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Figure §.§ Com petition radioligand binding to transfected m am m alian cells. Cultured 
mammalian tsA201 cells were cotransfected with subunit chimaeras a9(L209)/5-HT3A and 
a 10(L206)/5-HT3A (in which the extracellular N-terminal domain o f  the a9 or alO subunits are 
fused to the transmembrane and intracellular domain o f  the mouse 5-HT3A subunit). 
Competition-binding data with neramexane, memantine, and tubocurarine is presented as a 
percentage o f  [3H]MLA binding obtained in the absence o f  competing ligand. The curves are 
from a single experiment but are typical o f  three independent experiments. Error bars = SEM  
and represent triplicate values.
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binding indicated a substantially lower affinity (~7000-fold and ~700-fold, 
respectively). Moreover, no displacement of [3H]MLA was observed at 
concentrations which gave full antagonist activity in oocytes. For comparison, 
competition binding was also performed with the nicotinic antagonist (+)- 
tubocurarine, which has previously been shown to displace [3H]MLA binding in 
a9xal0x nAChR expressing cells with high affinity (0.29 ± 0.09 pM; Baker et 
al., 2004), a concentration comparable to the /C50 values for neramexane and 
memantine obtained in oocytes. It would appear, therefore, that the antagonist 
activity of neramexane and memantine is not due to competitive binding with the 
agonist-binding site of the a9al0  nAChR.
5.7.3 Discussion
Pharmacological data has been obtained which indicates that the block of 
acetylcholine-evoked responses of recombinant a9al0  nAChRs by neramexane 
and memantine is mediated via a non-competitive mechanism. The 
concentrations of neramexane and memantine required to effectively displace the 
high-affinity nicotinic radioligand [3H]MLA were ~7000-fold and ~700-fold 
higher, respectively, than the IC50 values determined in Xenopus oocytes (Plazas 
et al., 2007). The non-competitive mode of action of neramexane on the 
chimaeric a9al0  nAChR shown here (Figure 5.5) is supported by functional data 
from Xenopus oocytes expressing recombinant a9al0  nAChRs. At low 
micromolar concentrations of neramexane (3 pM) the maximal response to
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acetylcholine is reduced and is not overcome by higher concentrations of agonist, 
as would be expected for non-competitive inhibition.
Neramexane is being developed as an NMDA receptor antagonist for use in 
therapeutic applications and is currently in phase II of clinical trials. As discussed 
above it was selected for study due to the similarity in effects to the already well- 
established NMDA receptor blocker memantine, which has been used clinically 
for over ten years. It has previously been established that neramexane blocks 
NMDA and 5HT3A receptors with IC50 values in the low micro-molar range; lpM 
(Parsons et al., 1999a); and 2 pM (Rammes et al., 2001), respectively. In this 
study (Plazas et al., 2007), data has been obtained which demonstrates that 
neramexane also interacts with the a9al0 nAChR. Experiments conducted on rat 
inner hair cells have shown that neramexane can block acetylcholine-evoked 
responses with an /C50 value of 0.3 ± 0.08 pM, which is similar to its apparent 
affinity on recombinant a9al0 nAChRs reconstituted in oocytes (/C50 = 0.39 ± 
0.03 pM). Since the sub-micromolar apparent affinity of neramexane on a9al0 
nAChRs reported is higher than those found previously for the NMDA and 5- 
HT3A receptor, it might be of therapeutic significance. The plasma concentrations 
achieved with neramexane at therapeutic doses is around 0.4-1 pM, which is 
similar to the IC50 value obtained for the a9al0  nAChR in oocytes and on rat 
inner ear cells, described above. Thus, there is a possibility that neramexane 
could lead to the reduction or loss of function of this nAChR within the inner ear 
when used clinically.
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Chapter 6 
Conclusions and summary
A series of nAChR subunit loop chimaeras has been constructed with the aim of 
investigating the influence of the nAChR and 5 -HT3R large intracellular loop 
domain upon various receptor properties. Work presented in this thesis has 
demonstrated that the M3-M4 intracellular loop domain exerts a dramatic 
influence on subunit folding and assembly and on receptor cell-surface 
expression, intracellular targeting and function.
The loop chimaeras created in this study contain a common extracellular domain 
(derived from the nAChR a7 subunit) and common transmembrane regions 
(derived from the 5 -HT3A subunit). As has been demonstrated previously, these 
features facilitate both detection of expressed subunit chimaeras by aBTX and 
efficient homomeric receptor assembly (Eisele et al., 1993; Cooper and Millar, 
1998; Gee et al., 2007). Consequently, all of these loop chimaeras would be 
expected to bind [125I]aBTX unless subunit folding or assembly were disrupted by 
the intracellular loop domain. Interestingly, substantial differences in the levels of 
cell-surface [ I] aBTX binding with different loop chimaeras were observed 
(Figure 3.3). These differences appear not to be a consequence of differences in
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the level of expressed subunit protein, since loop chimaeras with high, low and 
intermediate levels of cell-surface [125I]aBTX binding were detected in similar 
amounts by immunoprecipitation of FLAG-tagged subunit chimaeras (Figure 3.5). 
It seems reasonable to assume, therefore, that the variation in levels of cell-surface 
binding are a consequence of differences in the proportion of total subunit protein 
transported to the cell surface and that this is a consequence of differences in 
receptor trafficking caused by variation in the intracellular loop domains.
All loop chimaeras were also examined using radioligand binding on disrupted 
cells, thereby permitting detection of intracellular, as well as cell-surface, 
receptors. Whereas some loop chimaeras could not be detected on the cell 
surface, (or gave very low levels of cell surface radioligand binding), all of the 
intracellular loop chimaeras gave detectable levels of specific radioligand binding 
in disrupted cell preparations (Figure 3.4). It is likely that the differences in the 
level of [3H]MLA binding reflect differences in the efficiency with which loop 
chimaeras are able to fold and oligomerise into a native conformation. 
Comparisons of the two sets of radioligand binding data indicate that intracellular 
loop domains influence both efficiency of subunit folding/assembly and also the 
proportion of correctly folded receptors which are transported to the cell surface. 
For example, the a5, a6 and a7 loop chimaeras have similar levels of [3H]MLA 
binding in disrupted cells (Figure 3.4) but very different levels of cell-surface 
[125I]aBTX binding (Figure 3.5).
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It has been shown previously in this laboratory that a FLIPR-based assay, 
measuring agonist-induced changes in intracellular calcium, provides a 
convenient method by which to assess whether nAChR/5-HT3R subunit chimaeras 
are able to generate functional receptors (Gee et a l, 2007). As expected, no 
evidence of functional expression was detected for loop chimaeras which failed to 
give cell-surface [125I]aBTX binding. As has been demonstrated previously for 
the a l  loop chimaera (Gee et al., 2007), clear evidence of functional expression 
was observed for the a3, a8, alO and 5 -HT3B loop chimaeras. Interestingly, there 
was not a good correlation between those chimaeras which displayed high levels 
of cell-surface [125I]aBTX binding and those for which clear evidence of 
functional expression could be detected. The a l and a4 loop chimaeras, for
I
example, give high levels of cell-surface [ IJaBTX binding but no evidence of 
functional expression. The a3 and alO loop chimaeras gave relatively low levels
19 Sof cell-surface [ IJaBTX binding, but clear evidence of functional expression. It 
appears, therefore, that the nAChR intracellular loop domain can also exert a 
profound influence upon the ability of subunits, once assembled, to generate 
functional receptors. Similar discrepancies between levels of radioligand binding 
and function have been reported in studies with other types of nAChR subunit 
chimaeras and with subunits altered by site-directed mutagenesis (Garcia-Guzman 
et al., 1994; Valor et al., 2002; Castelan et al., 2007; Gee et a l, 2007).
Despite the well established evidence that the conductance of Cys-loop type 
ligand-gated ion channels is influenced by amino acids located within the second
transmembrane domain, there is now strong evidence to indicate that channel 
conductance is also influenced by other subunit domains, including the M3-M4 
intracellular loop (Kelley et a l , 2003; Hales et a l, 2006; Gee et a l, 2007). Noise 
analysis of the loop chimaeras is entirely consistent with previous data implicating 
the intracellular loop in modulating channel conductance. It has been proposed 
that the influence of the intracellular loop domain is a consequence of positively 
charged amino acids (Kelley et a l, 2003; Hales et a l, 2006) and it has been 
demonstrated that the replacement of three arginine residues within the MA 
region of the 5 -HT3A subunit intracellular loop results in a dramatic increase in 
single channel conductance (Kelley et a l, 2003). Inspection of the MA region of 
the subunits examined in this study (a3, a7, a8 and a 10) indicates that our 
findings are in general agreement with the proposal that positively charged amino 
acids in this region are important (Figure 4.10). It is possible, however, that 
charged amino acids other than the three arginines mutated by Kelley et al. are 
able to exert an additional influence on single channel conductance of the loop 
chimaeras. There appears to be a trend, whereby loop chimaeras containing more 
positively charged residues and/or fewer negatively charged residues display 
lower single-channel conductances (Figure 4.10). The number of positively 
charged residues is greater and the overall net charge is more positive in the MA 
region of the nAChR loop chimaera with the lowest conductance (a 10) than in 
those with the highest conductance (a3, a7 and a8) although there appears to be 
no direct relationship between net charge and conductance as is observed for the 
M2 domain of the muscle nAChR (Imoto et a l, 1988).
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The results provide evidence that the rate of receptor desensitisation is influenced 
by the M3-M4 intracellular domain. This is perhaps a surprising finding, given 
that residues within the M2 transmembrane domain of nAChRs have been shown 
to be important in determining rates of receptor desensitisation (Revah et al., 
1991). There is, however, evidence that subunit domains other than M2 can 
influence desensitisation. Recent studies with nAChR/5-HT3R subunit chimaeras 
have demonstrated that the N-terminal extracellular domain can influence receptor 
desensitisation (Gee et ah, 2007). Taken together, these results indicate that 
receptor desensitisation can be influenced by a variety of subunit domains.
Use of nAChR/5-HT3R subunit chimaeras has also enabled the pharmacological 
characterisation of a9al0  nAChRs. Expression of a9/5-HT3A and al0/5-HT3A 
subunit chimaeras circumvents problems associated with the inefficient folding 
and assembly of a9al0  nAChRs in mammalian heterologous expression systems. 
Competition radioligand binding studies have been employed to complement 
electrophysiological studies of a9al0 nAChRs conducted in Dr Belen Egoyhen’s 
laboratory (Buenos Aires, Argentina) and have helped to determine whether these 
compounds are acting as either competitive or non-competitive antagonists.
In addition, preliminary studies with both 11ACI1R/5 -HT3R chimaeras and intact 
nAChR subunits have been performed to examine the influence of co-expression 
on a recently identified transmembrane molecular chaperone protein RIC-3 and 
the intracellular protein rapsyn. RIC-3 was found to dramatically attenuate the
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level of cell-surface loop chimaeric receptors. In addition, preliminary evidence 
was obtained concerning the ability of rapsyn to induce receptor clustering via 
interaction with the nAChR a l loop domain.
Thus, in the course of this study, subunit chimaeras have been employed 
successfully to investigate the influence of specific protein domains upon receptor 
properties. Further studies, building on the work presented here, will in future 
help to contribute greater insights into the cell biological and biophysical 
properties of nAChRs and their relatives in health and disease.
In summary, the main focus of this thesis was to investigate the influence of the 
nAChR M3-M4 intracellular loop domain, upon various aspects of receptor 
folding, assembly, targeting and function. To examine the influence of the M3- 
M4 intracellular loop domain in isolation, a series of chimaeric receptors was 
created which differ only in their loop domain region. The chimaeric receptor 
constructs all shared a common N-terminal domain from the a l  nAChR subunit, 
and the four-transmembrane domains from the 5-HT3aR subunit, facilitating 
homomeric assembly and expression in mammalian cell-lines. It was 
demonstrated that the large intracellular loop domain could dramatically influence 
cell-surface expression, targeting within the cell, and functional properties such as 
single-channel conductance and desensitisation.
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